The adoptive transfer of antigen-specific T cells that have been expanded ex vivo is being actively pursued to treat infections and malignancy in humans. The T cell populations that are available for adoptive immunotherapy include both effector memory and central memory cells, and these differ in phenotype, function, and homing. The efficacy of adoptive immunotherapy requires that transferred T cells persist in vivo, but identifying T cells that can reproducibly survive in vivo after they have been numerically expanded by in vitro culture has proven difficult. Here we show that in macaques, antigen-specific CD8+ T cell clones derived from central memory T cells, but not effector memory T cells, persisted long-term in vivo, reacquired phenotypic and functional properties of memory T cells, and occupied memory T cell niches. These results demonstrate that clonally derived CD8+ T cells isolated from central memory T cells are distinct from those derived from effector memory T cells and retain an intrinsic capacity that enables them to survive after adoptive transfer and revert to the memory cell pool. These results could have significant implications for the selection of T cells to expand or to engineer for adoptive immunotherapy of human infections or malignancy.
Carolina Berger, Michael C. Jensen, Peter M. Lansdorp, Mike Gough, Carole Elliott, Stanley R. Riddell
Title and authors | Publication | Year |
---|---|---|
TCR usage and epitope specificity amongst CD8+ and CD4+ SARS-CoV-2-specific T cells
Ulrik Fahnøe, Shan Feng, Alexander Underwood, Kivin Jacobsen, Amir Ameri, Thomas Blicher, Christina Sølund, Brad Rosenberg, Nina Weis, Liselotte Brix, Jens Bukh |
Frontiers in immunology | 2025 |
Enabling next-generation engineered TCR-T therapies based on high-throughput TCR discovery from diagnostic tumor biopsies
Kuilman T, Schrikkema DS, Gadiot J, Gomez-Eerland R, Bies L, Walker J, Spaapen RM, Kok H, Houg D, Viyacheva M, Claassen YB, Saornil M, Krijgsman O, Stringer B, Ding H, Geleijnse A, Meinema AC, Weissbrich B, Lancee M, Engele CG, Sabatino M, Chen PL, Tsai KY, Mulé JJ, Sondak VK, van den Bulk J, de Miranda NF, Jedema I, Haanen JG, van Heijst JW, Schumacher TN, Linnemann C, Bendle GM |
Nature Communications | 2025 |
LLT1 overexpression renders allogeneic-NK resistance and facilitates the generation of enhanced universal CAR-T cells
Zhu S, Zuo S, Li C, You X, Jiang E, Feng X, Luo Y |
Journal of Experimental & Clinical Cancer Research : CR | 2025 |
A multi-kinase inhibitor screen identifies inhibitors preserving stem-cell-like chimeric antigen receptor T cells
Song F, Tsahouridis O, Stucchi S, Walhart T, Mendell S, Hardy PB, Axtman M, Guduru SK, Gilbert TS, Graves LM, Herring LE, Savoldo B, Ma X, Woodcock M, Milner JJ, Ivanova A, Pearce KH, Xu Y, Dotti G |
Nature Immunology | 2025 |
Vaccine-induced T cell receptor T cell therapy targeting a glioblastoma stemness antigen
Chih YC, Dietsch AC, Koopmann P, Ma X, Agardy DA, Zhao B, De Roia A, Kourtesakis A, Kilian M, Krämer C, Suwala AK, Stenzinger M, Boenig H, Blum A, Pienkowski VM, Aman K, Becker JP, Feldmann H, Bunse T, Harbottle R, Riemer AB, Liu HK, Etminan N, Sahm F, Ratliff M, Wick W, Platten M, Green EW, Bunse L |
Nature Communications | 2025 |
Adoptive T Cell Therapy Targeting MAGE-A4
Chandora K, Chandora A, Saeed A, Cavalcante L |
Cancers | 2025 |
Tumor-specific CD8+ T cells from the bone marrow resist exhaustion and exhibit increased persistence in tumor-bearing hosts as compared with tumor-infiltrating lymphocytes
Zawidzka EM, Biavati L, Thomas A, Zanettini C, Marchionni L, Leone R, Borrello I |
Journal for Immunotherapy of Cancer | 2025 |
Adaptive immune responses against common viruses are sustained and functional in end-of-life patients
Olofsson A, Humbert M, Rekha RS, Frankling MH, Lund-Johansen F, Bergman P, Björkhem-Bergman L, Karlsson AC |
iScience | 2025 |
Safety, efficacy and total cost of point-of-care manufactured anti-CD19 CAR-T cell therapy in India: VELCART trial
Palani HK, Arunachalam AK, Kulkarni U, Yasar M, Venkatraman A, Palanikumar S, Radhakrishnan RN, Solomon M, Rajasekaran A, Bankar A, Datari PV, Selvarajan S, Korula A, Dash P, Schneider D, Wirthlin L, Abraham A, George B, Mathews V |
Molecular Therapy Oncology | 2025 |
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis
Gammelgaard OL, Terp MG, Kirkin AF, Johansen S, Traynor S, Vever H, Guldberg P, Kodahl AR, Gjerstorff MF, Ditzel HJ |
Molecular Cancer | 2024 |
CAR-T cell manufacturing: Major process parameters and next-generation strategies.
Ayala Ceja M, Khericha M, Harris CM, Puig-Saus C, Chen YY |
Journal of Experimental Medicine | 2024 |
"Digital twins elucidate critical role of T(scm) in clinical persistence of TCR-engineered cell therapy".
Joslyn LR, Huang W, Miles D, Hosseini I, Ramanujan S |
npj Systems Biology and Applications | 2024 |
Tipping the balance in autoimmunity: are regulatory t cells the cause, the cure, or both?
Hardtke-Wolenski M, Landwehr-Kenzel S |
Molecular and Cellular Pediatrics | 2024 |
Automated manufacture of ΔNPM1 TCR-engineered T cells for AML therapy
Yonezawa Ogusuku IE, Herbel V, Lennartz S, Brandes C, Argiro E, Fabian C, Hauck C, Hoogstraten C, Veld S, Hageman L, Teppert K, Koutsoumpli G, Griffioen M, Mockel-Tenbrinck N, Schaser T, de Groot R, Johnston IC, Lock D |
2024 | |
Exploring the evolution of T cell function and diversity across different stages of non-small cell lung cancer
Chang CY, Chang SC, Wei YF, Tseng YT, Chou CH, Chen YY, Chen CY, Ye YL |
American journal of cancer research | 2024 |
PD-1 downregulation enhances CAR-T cell antitumor efficiency by preserving a cell memory phenotype and reducing exhaustion.
Ouyang W, Jin SW, Xu N, Liu WY, Zhao H, Zhang L, Kang L, Tao Y, Liu Y, Wang Y, Wang J, Liu F, Yu L, Liu Z, Mi JQ |
Journal for ImmunoTherapy of Cancer | 2024 |
Peripheral T Cell Subpopulations as a Potential Surrogate Biomarker during Atezolizumab plus Bevacizumab Treatment for Hepatocellular Carcinoma.
Shirane Y, Fujii Y, Ono A, Nakahara H, Hayes CN, Miura R, Murakami S, Sakamoto N, Uchikawa S, Fujino H, Nakahara T, Murakami E, Yamauchi M, Miki D, Kawaoka T, Arihiro K, Tsuge M, Oka S |
Cancers | 2024 |
Novel and multiple targets for chimeric antigen receptor-based therapies in lymphoma.
Pang Y, Ghosh N |
Frontiers in Oncology | 2024 |
Higher TIGIT+ γδ T(CM) cells may predict poor prognosis in younger adult patients with non-acute promyelocytic AML.
Hou Q, Wang P, Kong X, Chen J, Yao C, Luo X, Li Y, Jin Z, Wu X |
Frontiers in immunology | 2024 |
The Confounding Role of Graft-Versus-Host Disease in Animal Models of Cancer Immunotherapy: A Systematic Review.
Ashraf H, Heydarnejad M, Kosari F |
Archives of Iranian medicine | 2024 |
EBV T-cell immunotherapy generated by peptide selection has enhanced effector functionality compared to LCL stimulation
Cooper RS, Sutherland C, Smith LM, Cowan G, Barnett M, Mitchell D, McLean C, Imlach S, Hayes A, Zahra S, Manchanayake C, Vickers MA, Graham G, McGowan NW, Turner ML, Campbell JD, Fraser AR |
Frontiers in immunology | 2024 |
Influencing factors and solution strategies of chimeric antigen receptor T-cell therapy (CAR–T) cell immunotherapy
WANG Z, ZHOU L, WU X |
Oncology Research | 2024 |
Targeting the membrane-proximal C2-set domain of CD33 for improved CAR T cell therapy
Fiorenza S, Lim SY, Laszlo GS, Kimble EL, Phi TD, Lunn-Halbert MC, Kirchmeier DR, Huo J, Kiem HP, Turtle CJ, Walter RB |
Molecular Therapy Oncology | 2024 |
HA-1–targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation
Krakow EF, Brault M, Summers C, Cunningham TM, Biernacki MA, Black RG, Woodward KB, Vartanian N, Kanaan SB, Yeh AC, Dossa RG, Bar M, Cassaday RD, Dahlberg A, Till BG, Denker AE, Yeung CC, Gooley TA, Maloney DG, Riddell SR, Greenberg PD, Chapuis AG, Newell EW, Furlan SN, Bleakley M |
Blood | 2024 |
Genetically modified and unmodified cellular approaches to enhance graft versus leukemia effect, without increasing graft versus host disease: the use of allogeneic cytokine-induced killer cells
Rambaldi B, Rizzuto G, Rambaldi A, Introna M |
Frontiers in Immunology | 2024 |
Choice of activation protocol impacts the yield and quality of CAR T cell product, particularly with older individuals
Mehta PH, Trollope GS, Leung P, Chinni SS, Iasinskaia A, Harrison AJ, Hughes\u2010Parry H, Jenkins MR, Kershaw MH, Jaworowski A, Slaney CY, Koldej RM, Ritchie DS, Quinn KM |
Clinical & Translational Immunology | 2024 |
Rapidly Manufactured CAR-T with Conserved Cell Stemness and Distinctive Cytokine-Secreting Profile Shows Improved Anti-Tumor Efficacy
Tsao ST, Gu M, Xiong Q, Deng Y, Deng T, Fu C, Zhao Z, Zhang H, Liu C, Zhong X, Xiang F, Huang F, Wang H |
Vaccines | 2024 |
Acute Myeloid Leukemia Skews Therapeutic WT1-specific CD8 TCR-T Cells Towards an NK-like Phenotype that Compromises Function and Persistence
Mazziotta F, Martin LE, Eagan DN, Bar M, Kinsella S, Paulson KG, Voillet V, Lahman MC, Hunter D, Schmitt TM, Duerkopp N, Yeung C, Tang TH, Gottardo R, Asano Y, Wilcox EC, Lee B, Zhang T, Lopedote P, Penter L, Wu CJ, Milano F, Greenberg PD, Chapuis AG |
medRxiv | 2024 |
Analysis of causes for poor persistence of CAR-T cell therapy in vivo
Kong Y, Tang L, You Y, Li Q, Zhu X |
Frontiers in immunology | 2023 |
Tuned activation of MSLN-CAR T cells induces superior antitumor responses in ovarian cancer models
Schoutrop E, Poiret T, El-Serafi I, Zhao Y, He R, Moter A, Henriksson J, Hassan M, Magalhaes I, Mattsson J |
Journal for ImmunoTherapy of Cancer | 2023 |
Comparative Pre-Clinical Analysis of CD20-Specific CAR T Cells Encompassing 1F5-, Leu16-, and 2F2-Based Antigen-Recognition Moieties
Belovezhets T, Kulemzin S, Volkova O, Najakshin A, Taranin A, Gorchakov A |
International journal of molecular sciences | 2023 |
Deconvolution of clinical variance in CAR-T cell pharmacology and response.
Kirouac DC, Zmurchok C, Deyati A, Sicherman J, Bond C, Zandstra PW |
Nature Biotechnology | 2023 |
CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naïve/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
Larson SM, Walthers CM, Ji B, Ghafouri SN, Naparstek J, Trent J, Chen JM, Roshandell M, Harris C, Khericha M, Schweppe T, Berent-Maoz B, Gosliner SB, Almaktari A, Ceja MA, Allen-Auerbach MS, Said J, Nawaly K, Mead M, de Vos S, Young PA, Oliai C, Schiller GJ, Timmerman JM, Ribas A, Chen YY |
Cancer Discovery | 2023 |
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy.
Bhatia V, Kamat NV, Pariva TE, Wu LT, Tsao A, Sasaki K, Sun H, Javier G, Nutt S, Coleman I, Hitchcock L, Zhang A, Rudoy D, Gulati R, Patel RA, Roudier MP, True LD, Srivastava S, Morrissey CM, Haffner MC, Nelson PS, Priceman SJ, Ishihara J, Lee JK |
Nature Communications | 2023 |
Antitumor effect of CAR-T cells targeting transmembrane tumor necrosis factor alpha combined with PD-1 mAb on breast cancers
Ba H, Dai Z, Zhang Z, Zhang P, Yin B, Wang J, Li Z, Zhou X |
Journal for ImmunoTherapy of Cancer | 2023 |
Stepwise activities of mSWI/SNF family chromatin remodeling complexes direct T cell activation and exhaustion
Battistello E, Hixon KA, Comstock DE, Collings CK, Chen X, Hernaez JR, Lee S, Cervantes KS, Hinkley MM, Ntatsoulis K, Cesarano A, Hockemeyer K, Haining WN, Witkowski MT, Qi J, Tsirigos A, Perna F, Aifantis I, Kadoch C |
Molecular Cell | 2023 |
T cell immunotherapy for cervical cancer: challenges and opportunities
Yu L, Lanqing G, Huang Z, Xin X, Minglin L, Fa-hui L, Zou H, Min J |
Frontiers in immunology | 2023 |
Elderly CD8+ T cells in the focus for immunotherapeutic approaches
Lis A, Zöphel D |
Aging | 2023 |
A Potential Biomarker of Dynamic Change in Peripheral CD45RA−CD27+CD127+ Central Memory T Cells for Anti-PD-1 Therapy in Patients with Esophageal Squamous Cell Carcinoma
Sakuma M, Mimura K, Nakajima S, Kaneta A, Kikuchi T, Nirei A, Tada T, Hanayama H, Okayama H, Sakamoto W, Saito M, Momma T, Saze Z, Kono K |
Cancers | 2023 |
Single-cell transcriptomic profiling reveals immune cell heterogeneity in acute myeloid leukaemia peripheral blood mononuclear cells after chemotherapy.
Hu X, Cao D, Zhou Z, Wang Z, Zeng J, Hong WX |
Cellular oncology (Dordrecht) | 2023 |
Memory T Cells in the Immunoprevention of Cancer: A Switch from Therapeutic to Prophylactic Approaches.
Mittra S, Harding SM, Kaech SM |
Journal of immunology (Baltimore, Md. : 1950) | 2023 |
Tumor-Specific CD8+ T Cells from the Bone Marrow Resist Exhaustion and Exhibit Increased Persistence in Tumor-Bearing Hosts as Compared to Tumor Infiltrating Lymphocytes
Zawidzka EM, Biavati L, Thomas A, Zanettini C, Marchionni L, Leone R, Borrello I |
2023 | |
T cell memory revisited using single telomere length analysis
Roger L, Miners KL, Leonard L, Grimstead JW, Price DA, Baird DM, Ladell K |
Frontiers in immunology | 2023 |
Cell Granularity Reflects Immune Cell Function and Enables Selection of Lymphocytes with Superior Attributes for Immunotherapy
Wu T, Tan JH, Sin W, Luah YH, Tan SY, Goh M, Birnbaum ME, Chen Q, Cheow LF |
Advanced Science | 2023 |
Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T Cell Therapy in Adults with high-risk Relapsed/Refractory ALL
Aldoss I, Khaled SK, Wang X, Palmer J, Wang Y, Wagner JR, Clark MC, Simpson J, Paul J, Vyas V, Chien SH, Stein A, Pullarkat V, Salhotra A, Al Malki MM, Aribi A, Sandhu K, Thomas SH, Budde LE, Marcucci G, Brown CE, Forman SJ |
Clinical cancer research | 2023 |
CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models
Timpanaro A, Piccand C, Dzhumashev D, Anton-Joseph S, Robbi A, Moser J, Rössler J, Bernasconi M |
Journal of experimental & clinical cancer research : CR | 2023 |
Insights gained from single-cell analysis of chimeric antigen receptor T-cell immunotherapy in cancer
Tang L, Huang ZP, Mei H, Hu Y |
Military Medical Research | 2023 |
Tracking Peripheral Memory T Cell Subsets in Advanced Nonsmall Cell Lung Cancer Treated with Hypofractionated Radiotherapy and PD-1 Blockade
Kang P, Yu H, Li Y, Wen X, Ye H, Luo Y, Yang Y, Yuan Q, Lin S |
Journal of Oncology | 2023 |
INSPIRED Symposium Part 4B: Chimeric Antigen Receptor T Cell Correlative Studies-Established Findings and Future Priorities.
Ligon JA, Ramakrishna S, Ceppi F, Calkoen FGJ, Diorio C, Davis KL, Jacoby E, Gottschalk S, Schultz LM, Capitini CM |
Transplantation and cellular therapy | 2023 |
Antigen-Specific TCR-T Cells for Acute Myeloid Leukemia: State of the Art and Challenges
S Kang, Y Li, J Qiao, X Meng, Z He, X Gao, L Yu |
Frontiers in Oncology | 2022 |
The ER-Mitochondria Interface as a Dynamic Hub for T Cell Efficacy in Solid Tumors
E Hunt, A Andrews, S Larsen, J Thaxton |
Frontiers in Cell and Developmental Biology | 2022 |
Role of Suprabasin in the Dedifferentiation of Follicular Epithelial Cell-Derived Thyroid Cancer and Identification of Related Immune Markers
H Tan, L Wang, Z Liu |
Frontiers in Genetics | 2022 |
Rapid manufacturing of non-activated potent CAR T cells
S Ghassemi, J Durgin, S Nunez-Cruz, J Patel, J Leferovich, M Pinzone, F Shen, K Cummins, G Plesa, V Cantu, S Reddy, F Bushman, S Gill, U ODoherty, R OConnor, M Milone |
Nature Biomedical Engineering | 2022 |
Enhancing CAR T function with the engineered secretion of C. perfringens neuraminidase
J Durgin, R Thokala, L Johnson, E Song, J Leferovich, V Bhoj, S Ghassemi, M Milone, Z Binder, D O'Rourke, R O'Connor |
Molecular Therapy | 2022 |
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
A Khurana, Y Lin |
Current Treatment Options in Oncology | 2022 |
Novel CD19 chimeric antigen receptor T cells manufactured next-day for acute lymphoblastic leukemia
Zhang C, He J, Liu L, Wang J, Wang S, Liu L, Ge J, Gao L, Gao L, Kong P, Liu Y, Liu J, Han Y, Zhang Y, Sun Z, Ye X, Yin W, Sersch M, Shen L, Cao WW, Zhang X |
Blood Cancer Journal | 2022 |
Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment.
Bendtsen SK, Perez-Penco M, Hübbe ML, Martinenaite E, Orebo Holmström M, Weis-Banke SE, Grønne Dahlager Jørgensen N, Jørgensen MA, Munir Ahmad S, Jensen KM, Friese C, Lundsager MT, Johansen AZ, Carretta M, Ødum N, Met Ö, Svane IM, Madsen DH, Andersen MH |
OncoImmunology | 2022 |
Monitoring of Circulating CAR T Cells: Validation of a Flow Cytometric Assay, Cellular Kinetics, and Phenotype Analysis Following Tisagenlecleucel.
Peinelt A, Bremm M, Kreyenberg H, Cappel C, Banisharif-Dehkordi J, Erben S, Rettinger E, Jarisch A, Meisel R, Schlegel PG, Beck O, Bug G, Klusmann JH, Klingebiel T, Huenecke S, Bader P |
Frontiers in immunology | 2022 |
The Impact of Esophageal Oncological Surgery on Perioperative Immune Function; Implications for Adjuvant Immune Checkpoint Inhibition
Donlon NE, Davern M, Sheppard AD, O\u2019Connell F, Dunne MR, Hayes C, Mylod E, Ramjit S, Temperley H, Mac Lean M, Cotter G, Bhardwaj A, Butler C, Conroy MJ, O\u2019Sullivan J, Ravi N, Donohoe CL, Reynolds JV, Lysaght J |
Frontiers in immunology | 2022 |
Impact of Manufacturing Procedures on CAR T Cell Functionality
Watanabe N, Mo F, McKenna MK |
Frontiers in immunology | 2022 |
Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy products
Durkee-Shock J, Lazarski CA, Jensen-Wachspress MA, Zhang A, Son A, Kankate VV, Field NE, Webber K, Lang H, Conway SR, Hanley PJ, Bollard CM, Keller MD, Schwartz DM |
2022 | |
CAR T-Cell Therapy Predictive Response Markers in Diffuse Large B-Cell Lymphoma and Therapeutic Options After CART19 Failure
Caballero AC, Escribà-Garcia L, Alvarez-Fernández C, Briones J |
Frontiers in immunology | 2022 |
Hypoxia-inducible lentiviral gene expression in engineered human macrophages.
Chinn HK, Gardell JL, Matsumoto LR, Labadie KP, Mihailovic TN, Lieberman NAP, Davis A, Pillarisetty VG, Crane CA |
Journal for ImmunoTherapy of Cancer | 2022 |
High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion.
Caballero AC, Escribà-Garcia L, Pujol-Fernández P, Escudero-López E, Ujaldón-Miró C, Montserrat-Torres R, Sierra J, Alvarez-Fernández C, Briones J |
Cancer Gene Therapy | 2022 |
Biomarker correlates with response to NY-ESO-1 TCR T cells in patients with synovial sarcoma.
Gyurdieva A, Zajic S, Chang YF, Houseman EA, Zhong S, Kim J, Nathenson M, Faitg T, Woessner M, Turner DC, Hasan AN, Glod J, Kaplan RN, D'Angelo SP, Araujo DM, Chow WA, Druta M, Demetri GD, Van Tine BA, Grupp SA, Fine GD, Eleftheriadou I |
Nature Communications | 2022 |
Applying a clinical lens to animal models of CAR-T cell therapies
Duncan BB, Dunbar CE, Ishii K |
2022 | |
Generation and Functional Characterization of PLAP CAR-T Cells against Cervical Cancer Cells
Yekehfallah V, Pahlavanneshan S, Sayadmanesh A, Momtahan Z, Ma B, Basiri M |
Biomolecules | 2022 |
Treatment of aggressive T-cell lymphoma/leukemia with anti-CD4 CAR T cells.
Feng J, Xu H, Cinquina A, Wu Z, Zhang W, Sun L, Chen Q, Tian L, Song L, Pinz KG, Wada M, Jiang X, Hanes WM, Ma Y, Zhang H |
Frontiers in immunology | 2022 |
Chimeric antigen receptor engineered T cells and their application in the immunotherapy of solid tumours.
Mao R, Hussein MS, He Y |
Expert Reviews in Molecular Medicine | 2022 |
Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy®: real-world experience and cost analysis in India.
Palani HK, Arunachalam AK, Yasar M, Venkatraman A, Kulkarni U, Lionel SA, Selvarajan S, Korula A, Abraham A, George B, Adair JE, Orentas R, Dropulic B, Mathews V |
Bone Marrow Transplantation | 2022 |
Expression profile and prognostic values of LSM family in skin cutaneous melanoma.
Sun X, Zhang J, Xiao C, Ge Z |
BMC Medical Genomics | 2022 |
Expression of TRX1 optimizes the antitumor functions of human CAR T cells and confers resistance to a pro-oxidative tumor microenvironment
Balta E, Janzen N, Kirchgessner H, Toufaki V, Orlik C, Liang J, Lairikyengbam D, Abken H, Niesler B, Müller-Decker K, Ruppert T, Samstag Y |
Frontiers in immunology | 2022 |
Manipulating T-cell metabolism to enhance immunotherapy in solid tumor
Chen C, Wang Z, Ding Y, Qin Y |
Frontiers in immunology | 2022 |
AIM™ platform: A new immunotherapy approach for viral diseases.
Langan D, Wang R, Tidwell K, Mitiku S, Farrell A, Johnson C, Parks A, Suarez L, Jain S, Kim S, Jones K, Oelke M, Zeldis J |
Frontiers in Medicine | 2022 |
Delineation of T cell subsets in chronic rhinosinusitis with nasal polyps
Zahran AM, El-Badaway O, Elsayh IK, Osman MM |
Acta Otorhinolaryngologica Italica | 2022 |
Cellular Cancer Immunotherapy Development and Manufacturing in the Clinic
Fenton GA, Mitchell DA |
Clinical cancer research | 2022 |
Development of a cGMP-compliant process to manufacture donor-derived, CD45RA-depleted memory CD19-CAR T cells.
Kim-Hoehamer YI, Riberdy JM, Zheng F, Park JJ, Shang N, Métais JY, Lockey T, Willis C, Akel S, Moore J, Meagher MM, Velasquez MP, Triplett BM, Talleur AC, Gottschalk S, Zhou S |
Gene Therapy | 2022 |
Expansion of donor-unrestricted MAIT cells with enhanced cytolytic function suitable for TCR-redirection
Tiphaine Parrot, Katie Healy, Caroline Boulouis, Michał J. Sobkowiak, Edwin Leeansyah, Soo Aleman, Antonio Bertoletti, Margaret Sällberg Chen, Johan K. Sandberg |
JCI Insight | 2021 |
Immune inactivation of anti-simian immunodeficiency virus chimeric antigen receptor T cells in rhesus macaques
F Haeseleer, Y Fukazawa, H Park, B Varco-Merth, BJ Rust, JV Smedley, K Eichholz, CW Peterson, R Mason, HP Kiem, M Roederer, LJ Picker, AA Okoye, L Corey |
Molecular Therapy — Methods & Clinical Development | 2021 |
Protective T cell receptor identification for orthotopic reprogramming of immunity in refractory virus infections
TA Stief, T Kaeuferle, TR Müller, M Döring, LM Jablonowski, K Schober, J Feucht, KM Dennehy, S Willier, F Blaeschke, R Handgretinger, P Lang, DH Busch, T Feuchtinger |
Molecular Therapy | 2021 |
Metabolic barriers to cancer immunotherapy
K DePeaux, GM Delgoffe |
Nature Reviews Immunology | 2021 |
Improving CAR T-Cell Persistence
V Pietrobon, LA Todd, A Goswami, O Stefanson, Z Yang, F Marincola |
International journal of molecular sciences | 2021 |
A Correlation Between Differentiation Phenotypes of Infused T Cells and Anti-Cancer Immunotherapy
H Ren, K Cao, M Wang |
Frontiers in immunology | 2021 |
Early memory differentiation and cell death resistance in T cells predicts melanoma response to sequential anti-CTLA4 and anti-PD1 immunotherapy
I Vanmeerbeek, DM Borras, J Sprooten, O Bechter, S Tejpar, AD Garg |
Genes and Immunity | 2021 |
Ectopic activation of the miR-200c–EpCAM axis enhances antitumor T cell responses in models of adoptive cell therapy
M Zhang, Z Zhao, Y Pritykin, M Hannum, AC Scott, F Kuo, V Sanghvi, TA Chan, V Seshan, HG Wendel, A Schietinger, M Sadelain, M Huse |
Science Translational Medicine | 2021 |
CAR T cells: Building on the CD19 paradigm
AG Levin, I Rivière, Z Eshhar, M Sadelain |
European Journal of Immunology | 2021 |
The Promise of Personalized TCR-Based Cellular Immunotherapy for Cancer Patients
M Arnaud, S Bobisse, J Chiffelle, A Harari |
Frontiers in immunology | 2021 |
HIV-1-Specific CAR-T Cells With Cell-Intrinsic PD-1 Checkpoint Blockade Enhance Anti-HIV Efficacy in vivo
Z Jiang, H Liang, H Pan, Y Liang, H Wang, X Yang, P Lu, X Zhang, J Yang, D Zhang, X Shen, J Wang, Z Liang, Q Lin, Y Wang, L Zhao, Y Zhong, H Lu, H Zhu |
Frontiers in microbiology | 2021 |
CAR T cell therapy as a promising approach in cancer immunotherapy: challenges and opportunities
M Akhoundi, M Mohammadi, SS Sahraei, M Sheykhhasan, N Fayazi |
Cellular Oncology | 2021 |
Generation of Pure Highly Functional Human Anti-Tumor Specific Cytotoxic T Lymphocytes With Stem Cell-Like Memory Features for Melanoma Immunotherapy
M Hamieh, JF Chatillon, E Dupel, F Bayeux, E Fauquembergue, P Maby, A Drouet, AB Duval-Modeste, S Adriouch, O Boyer, JB Latouche |
Frontiers in immunology | 2021 |
PI3K in T Cell Adhesion and Trafficking
KH Johansen, DP Golec, JH Thomsen, PL Schwartzberg, K Okkenhaug |
Frontiers in immunology | 2021 |
In vitro OP9-DL1 co-culture and subsequent maturation in the presence of IL-21 generates tumor antigen-specific T cells with a favorable less-differentiated phenotype and enhanced functionality
S Bonte, S de Munter, L Billiet, G Goetgeluk, J Ingels, H Jansen, M Pille, L de Cock, K Weening, T Taghon, G Leclercq, B Vandekerckhove, T Kerre |
OncoImmunology | 2021 |
Memory stem T cells modified with a redesigned CD30‐chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma
C AlvarezFernández, L EscribàGarcia, AC Caballero, E EscuderoLópez, C UjaldónMiró, R MontserratTorres, P PujolFernández, J Sierra, J Briones |
IBMS BoneKEy | 2021 |
Heterodimeric IL-15 in Cancer Immunotherapy
C Bergamaschi, V Stravokefalou, D Stellas, S Karaliota, BK Felber, GN Pavlakis |
Cancers | 2021 |
Genetic Modification of Tumor-Infiltrating Lymphocytes via Retroviral Transduction
H Weinstein-Marom, G Gross, M Levi, H Brayer, J Schachter, O Itzhaki, MJ Besser |
Frontiers in immunology | 2021 |
Prognostic and therapeutic TILs of cervical cancer—Current advances and future perspectives
Y Tang, AX Zhang, G Chen, Y Wu, W Gu |
Molecular Therapy — Oncolytics | 2021 |
Clonal expansion of T memory stem cells determines early anti-leukemic responses and long-term CAR T cell persistence in patients
L Biasco, N Izotova, C Rivat, S Ghorashian, R Richardson, A Guvenel, R Hough, R Wynn, B Popova, A Lopes, M Pule, AJ Thrasher, PJ Amrolia |
2021 | |
Chimeric antigen receptor T cells engineered to secrete CD40 agonist antibodies enhance antitumor efficacy
Y Zhang, P Wang, T Wang, Y Fang, Y Ding, Q Qian |
Journal of Translational Medicine | 2021 |
An overview of multiplexed analyses of CAR T-cell therapies: insights and potential
BP DePriest, N Vieira, A Bidgoli, S Paczesny |
Expert Review of Proteomics | 2021 |
Early Survival Prediction Framework in CD19-Specific CAR-T Cell Immunotherapy Using a Quantitative Systems Pharmacology Model
A Mueller-Schoell, N Puebla-Osorio, R Michelet, MR Green, A Künkele, W Huisinga, P Strati, B Chasen, SS Neelapu, C Yee, C Kloft |
Cancers | 2021 |
Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward
PS Kozani, PS Kozani, F Rahbarizadeh |
Frontiers in immunology | 2021 |
Targeted T cell receptor gene editing provides predictable T cell product function for immunotherapy
TR Müller, S Jarosch, M Hammel, J Leube, S Grassmann, B Bernard, M Effenberger, I Andrä, MZ Chaudhry, T Käuferle, A Malo, L Cicin-Sain, P Steinberger, T Feuchtinger, U Protzer, K Schumann, M Neuenhahn, K Schober, DH Busch |
Reproduction | 2021 |
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. VII. Present and future of technologies for production of CAR cell therapies
RN Ramos, V Picanço-Castro, TG Oliveira, AM Junior, GC Santis, MH Bonamino, V Rocha |
2021 | |
T Cell Fitness and Autologous CAR T Cell Therapy in Haematologic Malignancy
PH Mehta, S Fiorenza, RM Koldej, A Jaworowski, DS Ritchie, KM Quinn |
Frontiers in immunology | 2021 |
Clinical Significance of Composition Changes in T-cell Subpopulations After Chemotherapy in Patients With Gastric Cancer
YEO MK, SUN P, CHUNG C, PARK JH, KANG SH, MOON HS, SUNG JK, JEONG HY, KIM JS |
In vivo (Athens, Greece) | 2021 |
Arming Immune Cell Therapeutics with Polymeric Prodrugs.
López CL, Brempelis KJ, Matthaei JF, Montgomery KS, Srinivasan S, Roy D, Huang F, Kreuser SA, Gardell JL, Blumenthal I, Chiefari J, Jensen MC, Crane CA, Stayton PS |
Advanced Healthcare Materials | 2021 |
Antigen-specific B-cell depletion for precision therapy of mucosal pemphigus vulgaris
Jinmin Lee, Daniel K. Lundgren, Xuming Mao, Silvio Manfredo-Vieira, Selene Nunez-Cruz, Erik F. Williams, Charles-Antoine Assenmacher, Enrico Radaelli, Sangwook Oh, Baomei Wang, Christoph T. Ellebrecht, Joseph A. Fraietta, Michael C. Miloneǂ, Aimee S. Payne |
Journal of Clinical Investigation | 2020 |
Single-cell transcriptomics identifies multiple pathways underlying antitumor function of TCR- and CD8αβ-engineered human CD4 + T cells
JA Rath, G Bajwa, B Carreres, E Hoyer, I Gruber, MA Martínez-Paniagua, YR Yu, N Nouraee, F Sadeghi, M Wu, T Wang, M Hebeisen, N Rufer, N Varadarajan, PC Ho, MK Brenner, D Gfeller, C Arber |
Science Advances | 2020 |
Adoptive Cell Therapy—Harnessing Antigen-Specific T Cells to Target Solid Tumours
E Chruściel, Z Urban-Wójciuk, Ł Arcimowicz, M Kurkowiak, J Kowalski, M Gliwiński, T Marjański, W Rzyman, W Biernat, R Dziadziuszko, C Montesano, R Bernardini, N Marek-Trzonkowska |
Cancers | 2020 |
Engineering T cells for immunotherapy of primary human hepatocellular carcinoma
LD Galva, L Cai, Y Shao, Y He |
Journal of genetics and genomics = Yi chuan xue bao | 2020 |
Engineering Solutions for Mitigation of Chimeric Antigen Receptor T-Cell Dysfunction
A Gavriil, M Barisa, E Halliwell, J Anderson |
Cancers | 2020 |
Memory T cells: strategies for optimizing tumor immunotherapy
Q Liu, Z Sun, L Chen |
Protein & Cell | 2020 |
Point-Of-Care CAR T-Cell Production (ARI-0001) Using a Closed Semi-automatic Bioreactor: Experience From an Academic Phase I Clinical Trial
M Castella, M Caballero-Baños, V Ortiz-Maldonado, EA González-Navarro, G Suñé, A Antoñana-Vidósola, A Boronat, B Marzal, L Millán, B Martín-Antonio, J Cid, M Lozano, E García, J Tabera, E Trias, U Perpiña, JM Canals, T Baumann, D Benítez-Ribas, E Campo, J Yagüe, Á Urbano-Ispizua, S Rives, J Delgado, M Juan |
Frontiers in immunology | 2020 |
TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals
F Manfredi, BC Cianciotti, A Potenza, E Tassi, M Noviello, A Biondi, F Ciceri, C Bonini, E Ruggiero |
Frontiers in immunology | 2020 |
Current Advances in Osteosarcoma: Clinical Perspectives: Past, Present and Future
ES Kleinerman, R Gorlick |
2020 | |
‘Off-the-shelf’ allogeneic CAR T cells: development and challenges
S Depil, P Duchateau, SA Grupp, G Mufti, L Poirot |
Nature Reviews Drug Discovery | 2020 |
Human macrophages engineered to secrete a bispecific T cell engager support antigen-dependent T cell responses to glioblastoma
JL Gardell, LR Matsumoto, H Chinn, KR DeGolier, SA Kreuser, B Prieskorn, S Balcaitis, A Davis, RG Ellenbogen, CA Crane |
Journal for ImmunoTherapy of Cancer | 2020 |
Breaking Bottlenecks for the TCR Therapy of Cancer
L Gaissmaier, M Elshiaty, P Christopoulos |
Cells | 2020 |
Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma
E Zah, E Nam, V Bhuvan, U Tran, BY Ji, SB Gosliner, X Wang, CE Brown, YY Chen |
Nature Communications | 2020 |
Minor Histocompatibility Antigen-Specific T Cells
C Summers, VS Sheth, M Bleakley |
Frontiers in Pediatrics | 2020 |
Humanized Mice Are Precious Tools for Preclinical Evaluation of CAR T and CAR NK Cell Therapies
R Mhaidly, E Verhoeyen |
Cancers | 2020 |
Orthotopic T-Cell Receptor Replacement—An “Enabler” for TCR-Based Therapies
K Schober, TR Müller, DH Busch |
Cells | 2020 |
Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
R Gu, F Liu, D Zou, Y Xu, Y Lu, B Liu, W Liu, X Chen, K Liu, Y Guo, X Gong, R Lv, X Chen, C Zhou, M Zhong, H Wang, H Wei, Y Mi, L Qiu, L Lv, M Wang, Y Wang, X Zhu, J Wang |
Journal of Hematology & Oncology | 2020 |
AIM Platform: A Novel Nano Artificial Antigen-Presenting Cell-Based Clinical System Designed to Consistently Produce Multi-Antigen-Specific T-Cell Products with Potent and Durable Anti-Tumor Properties
L Suarez, R Wang, S Carmer, D Bednarik, H Myint, K Jones, M Oelke |
Transfusion Medicine and Hemotherapy | 2020 |
A Bird’s-Eye View of Cell Sources for Cell-Based Therapies in Blood Cancers
B Motais, S Charvátová, M Hrdinka, M Šimíček, T Jelínek, T Ševčíková, Z Kořístek, R Hájek, JR Bagó |
Cancers | 2020 |
CARs: Beyond T Cells and T Cell-Derived Signaling Domains
NM Sievers, J Dörrie, N Schaft |
International journal of molecular sciences | 2020 |
CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B*35 control Epstein-Barr virus-associated lymphoproliferation
AC Dragon, K Zimmermann, T Nerreter, D Sandfort, J Lahrberg, S Klöß, C Kloth, C Mangare, A Bonifacius, S Tischer-Zimmermann, R Blasczyk, B Maecker-Kolhoff, B Uchanska-Ziegler, H Abken, A Schambach, M Hudecek, B Eiz-Vesper |
Journal for ImmunoTherapy of Cancer | 2020 |
The Role of Circulating Tumor Cells in the Metastatic Cascade: Biology, Technical Challenges, and Clinical Relevance
H Dianat-Moghadam, M Azizi, Z Eslami-S, LE Cortés-Hernández, M Heidarifard, M Nouri, C Alix-Panabières |
Cancers | 2020 |
Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia
PA Atilla, MK McKenna, H Tashiro, M Srinivasan, F Mo, N Watanabe, BW Simons, AM Stevens, MS Redell, HE Heslop, M Mamonkin, MK Brenner, E Atilla |
Journal for ImmunoTherapy of Cancer | 2020 |
Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression
AF Rendeiro, J Casano, CK Vorkas, H Singh, A Morales, RA DeSimone, GB Ellsworth, R Soave, SN Kapadia, K Saito, CD Brown, JM Hsu, C Kyriakides, S Chiu, LV Cappelli, MT Cacciapuoti, W Tam, L Galluzzi, PD Simonson, O Elemento, M Salvatore, G Inghirami |
2020 | |
Expamers: a new technology to control T cell activation
MP Poltorak, P Graef, C Tschulik, M Wagner, V Cletiu, S Dreher, B Borjan, SP Fraessle, M Effenberger, M Turk, DH Busch, J Plitzko, DG Kugler, S Ragan, T Schmidt, C Stemberger, L Germeroth |
Scientific Reports | 2020 |
Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo
AT Teck, S Urban, P Quass, A Nelde, H Schuster, A Letsch, A Busse, JS Walz, U Keilholz, S Ochsenreither |
Cancer Immunology, Immunotherapy | 2020 |
Virus-Specific T Cell Therapies for HIV: Lessons Learned From Hematopoietic Stem Cell Transplantation
PH Lee, MD Keller, PJ Hanley, CM Bollard |
Frontiers in Cellular and Infection Microbiology | 2020 |
Ex vivo enrichment of PRAME antigen‐specific T cells for adoptive immunotherapy using CD137 activation marker selection
KH Lee, K Gowrishankar, J Street, HM McGuire, F Luciani, B Hughes, M Singh, LE Clancy, DJ Gottlieb, KP Micklethwaite, E Blyth |
IBMS BoneKEy | 2020 |
Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer
AH Ko, AC Jordan, E Tooker, SF Lacey, RB Chang, Y Li, AP Venook, M Tempero, L Damon, L Fong, MH OHara, BL Levine, JJ Melenhorst, G Plesa, CH June, GL Beatty |
Molecular Therapy | 2020 |
Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapy
A Sheih, V Voillet, LA Hanafi, HA DeBerg, M Yajima, R Hawkins, V Gersuk, SR Riddell, DG Maloney, ME Wohlfahrt, D Pande, MR Enstrom, HP Kiem, JE Adair, R Gottardo, PS Linsley, CJ Turtle |
Nature Communications | 2020 |
Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses
KJ Brempelis, CM Cowan, SA Kreuser, KP Labadie, BM Prieskorn, NA Lieberman, CI Ene, KW Moyes, H Chinn, KR DeGolier, LR Matsumoto, SK Daniel, JK Yokoyama, AD Davis, VJ Hoglund, KS Smythe, SD Balcaitis, MC Jensen, RG Ellenbogen, JS Campbell, RH Pierce, EC Holland, VG Pillarisetty, CA Crane |
Journal for ImmunoTherapy of Cancer | 2020 |
IL-2 enhances ex vivo–expanded regulatory T-cell persistence after adoptive transfer
SN Furlan, K Singh, C Lopez, V Tkachev, DJ Hunt, J Hibbard, KM Betz, BR Blazar, C Trapnell, LS Kean |
Blood Advances | 2020 |
Chimeric Antigen Receptor Based Therapy as a Potential Approach in Autoimmune Diseases: How Close Are We to the Treatment?
MS Nezhad, A Seifalian, N Bagheri, S Yaghoubi, MH Karimi, M Adbollahpour-Alitappeh |
Frontiers in immunology | 2020 |
The Art and Science of Selecting a CD123-Specific Chimeric Antigen Receptor for Clinical Testing
JM Riberdy, S Zhou, F Zheng, YI Kim, J Moore, A Vaidya, RE Throm, A Sykes, N Sahr, CL Bonifant, B Ryu, S Gottschalk, MP Velasquez |
Molecular Therapy — Methods & Clinical Development | 2020 |
Effect of Cellular-Based Artificial Antigen Presenting Cells Expressing ICOSL, in T-cell Subtypes Differentiation and Activation
Talebi M, Nozad Charoudeh H, Movassaghpour Akbari AA, Baradaran B, Kazemi T |
Advanced pharmaceutical bulletin | 2020 |
Acellular Wharton’s Jelly, Potentials in T-Cell Subtypes Differentiation, Activation and Proliferation
Talebi M, Nozad Charoudeh H, Movassaghpour Akbari AA, Baradaran B, Kazemi T |
Advanced pharmaceutical bulletin | 2020 |
Longitudinal immune profiling of mild and severe COVID-19 reveals innate and adaptive immune dysfunction and provides an early prediction tool for clinical progression
Rendeiro AF, Casano J, Kyriakos Vorkas C, Singh H, Morales A, DeSimone RA, Ellsworth GB, Soave R, Kapadia SN, Saito K, Brown CD, Hsu J, Kyriakides C, Chiu S, Cappelli L, Teresa Cacciapuoti M, Tam W, Galluzzi L, Simonson PD, Elemento O, Salvatore M, Inghirami G |
2020 | |
Improving CAR T cell immunotherapy-mediated remissions for pediatric Leukemia
David Barrett |
Journal of Clinical Investigation | 2019 |
CD19 CAR T cell product and disease attributes predict leukemia remission durability
Olivia C. Finney, Hannah M Brakke, Stephanie Rawlings-Rhea, Roxana Hicks, Danielle Doolittle, Marisa Lopez, Robert B. Futrell, Rimas J. Orentas, Daniel Li, Rebecca A Gardner, Michael C Jensen |
Journal of Clinical Investigation | 2019 |
CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration
Christopher L Nobles, Scott Sherrill-Mix, John K. Everett, Shantan Reddy, Joseph Fraietta, David Porter, Noelle Frey, Saar Gill, Stephan Grupp, Shannon L Maude, Don L Siegel, Bruce L Levine, Carl H. June, Simon F. Lacey, J. Joseph Melenhorst, Frederic Bushman |
Journal of Clinical Investigation | 2019 |
Surface-Engineered Lentiviral Vectors for Selective Gene Transfer into Subtypes of Lymphocytes
AM Frank, CJ Buchholz |
Molecular Therapy — Methods & Clinical Development | 2019 |
The making and function of CAR cells
M Zabel, PA Tauber, WF Pickl |
Immunology Letters | 2019 |
A long way to the battlefront: CAR T cell therapy against solid cancers
Z Wang, W Chen, X Zhang, Z Cai, W Huang |
Journal of Cancer | 2019 |
Baboon envelope LVs efficiently transduced human adult, fetal, and progenitor T cells and corrected SCID-X1 T-cell deficiency
O Bernadin, F Amirache, A Girard-Gagnepain, RD Moirangthem, C Lévy, K Ma, C Costa, D Nègre, C Reimann, D Fenard, A Cieslak, V Asnafi, H Sadek, R Mhaidly, M Cavazzana, C Lagresle-Peyrou, FL Cosset, I André, E Verhoeyen |
Blood Advances | 2019 |
Engineering for Success: Approaches to Improve Chimeric Antigen Receptor T Cell Therapy for Solid Tumors
M Mata, S Gottschalk |
Drugs | 2019 |
Multispecific Targeting with Synthetic Ankyrin Repeat Motif Chimeric Antigen Receptors
A Balakrishnan, A Rajan, AI Salter, PL Kosasih, Q Wu, J Voutsinas, MC Jensen, A Plückthun, SR Riddell |
Clinical cancer research | 2019 |
Targeted in-vitro-stimulation reveals highly proliferative multi-virus-specific human central memory T cells as candidates for prophylactic T cell therapy
B Faist, F Schlott, C Stemberger, KM Dennehy, A Krackhardt, M Verbeek, GU Grigoleit, M Schiemann, D Hoffmann, A Dick, K Martin, M Hildebrandt, DH Busch, M Neuenhahn, M Nevels |
PloS one | 2019 |
Switching on the green light for chimeric antigen receptor T-cell therapy
S Mardiana, J Lai, IG House, PA Beavis, PK Darcy |
IBMS BoneKEy | 2019 |
T cell immunotherapy enhanced by designer biomaterials
ZS Dunn, J Mac, P Wang |
Biomaterials | 2019 |
IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype
D Alizadeh, RA Wong, X Yang, D Wang, JR Pecoraro, CF Kuo, B Aguilar, Y Qi, DK Ann, R Starr, R Urak, X Wang, SJ Forman, CE Brown |
Cancer immunology research | 2019 |
Toward the development of true “off-the-shelf” synthetic T-cell immunotherapy
S Iriguchi, S Kaneko |
Cancer Science | 2019 |
CAR T Cells: A Snapshot on the Growing Options to Design a CAR
A Holzinger, H Abken |
2019 | |
Expansion and activation of distinct central memory T lymphocyte subsets in complex regional pain syndrome
MA Russo, NT Fiore, C van Vreden, D Bailey, DM Santarelli, HM McGuire, BF de St Groth, PJ Austin |
Journal of Neuroinflammation | 2019 |
Engineering an Artificial T‐Cell Stimulating Matrix for Immunotherapy
JW Hickey, Y Dong, JW Chung, SF Salathe, HC Pruitt, X Li, C Chang, AK Fraser, CA Bessell, AJ Ewald, S Gerecht, HQ Mao, JP Schneck |
Advanced materials (Deerfield Beach, Fla.) | 2019 |
Hypoxia Selectively Impairs CAR-T Cells In Vitro
R Berahovich, X Liu, H Zhou, E Tsadik, S Xu, V Golubovskaya, L Wu |
Cancers | 2019 |
Comprehensive Characterization of a Next-Generation Antiviral T-Cell Product and Feasibility for Application in Immunosuppressed Transplant Patients
L Amini, T Vollmer, DJ Wendering, A Jurisch, S Landwehr-Kenzel, NM Otto, K Jürchott, HD Volk, P Reinke, M Schmueck-Henneresse |
Frontiers in immunology | 2019 |
Large-scale expansion and characterization of CD3+ T-cells in the Quantum® Cell Expansion System
C Coeshott, B Vang, M Jones, B Nankervis |
Journal of Translational Medicine | 2019 |
Human Platelet Lysate Media Supplement Supports Lentiviral Transduction and Expansion of Human T Lymphocytes While Maintaining Memory Phenotype
E Canestrari, HR Steidinger, B McSwain, SJ Charlebois, CT Dann |
Journal of Immunology Research | 2019 |
Mycobacterium indicus pranii Induced Memory T-Cells in Lung Airways Are Sentinels for Improved Protection Against M.tb Infection
A Gupta, M Saqib, B Singh, L Pal, A Nishikanta, S Bhaskar |
Frontiers in immunology | 2019 |
T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant
AG Chapuis, DN Egan, M Bar, TM Schmitt, MS McAfee, KG Paulson, V Voillet, R Gottardo, GB Ragnarsson, M Bleakley, CC Yeung, P Muhlhauser, HN Nguyen, LA Kropp, L Castelli, F Wagener, D Hunter, M Lindberg, K Cohen, A Seese, MJ McElrath, N Duerkopp, TA Gooley, PD Greenberg |
Nature Medicine | 2019 |
S-15 in combination of Akt inhibitor promotes the expansion of CD45RA−CCR7+ tumor infiltrating lymphocytes with high cytotoxic potential and downregulating PD-1+Tim-3+ cells as well as regulatory T cells
B Xu, L Yuan, G Chen, T Li, J Zhou, C Zhang, P Qin, MM Muthana, S Wang, X Du, Q Gao |
Cancer Cell International | 2019 |
Activated Allogeneic Donor-derived Marrow-infiltrating Lymphocytes Display Measurable In Vitro Antitumor Activity
Biavati L, Noonan K, Luznik L, Borrello I |
Journal of immunotherapy (Hagerstown, Md. : 1997) | 2019 |
Glioblastoma-Targeted CD4+ CAR-T cells outperform CD8+ cells for Sustained Effector Function and Superior Antitumor Activity
Dongrui Wang, Brenda Aguilar, Renate Starr, Darya Alizadeh, Alfonso Brito, Aniee Sarkissian, Julie Ostberg, Stephen J. Forman, Christine Brown |
JCI Insight | 2018 |
Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells
S Ghassemi, S Nunez-Cruz, RS O'Connor, JA Fraietta, PR Patel, J Scholler, DM Barrett, SM Lundh, MM Davis, F Bedoya, C Zhang, J Leferovich, SF Lacey, BL Levine, SA Grupp, CH June, JJ Melenhorst, MC Milone |
Cancer immunology research | 2018 |
A primary role for human central memory cells in tissue immunosurveillance
A Gehad, JE Teague, TR Matos, V Huang, C Yang, R Watanabe, JT OMalley, CL Trimble, TS Kupper, RA Clark |
Blood Advances | 2018 |
Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells
AF Kirkin, KN Dzhandzhugazyan, P Guldberg, JJ Fang, RS Andersen, C Dahl, J Mortensen, T Lundby, A Wagner, I Law, H Broholm, L Madsen, C Lundell-Ek, MF Gjerstorff, HJ Ditzel, MR Jensen, W Fischer |
Nature Communications | 2018 |
Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer
N Manjarrez-Orduño, LC Menard, S Kansal, P Fischer, B Kakrecha, C Jiang, M Cunningham, D Greenawalt, V Patel, M Yang, R Golhar, JA Carman, S Lezhnin, H Dai, PS Kayne, SJ Suchard, SH Bernstein, SG Nadler |
Frontiers in immunology | 2018 |
Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies—the German Cancer Consortium approach
AM Krackhardt, B Anliker, M Hildebrandt, M Bachmann, SB Eichmüller, DM Nettelbeck, M Renner, L Uharek, G Willimsky, M Schmitt, WS Wels, M Schüssler-Lenz |
Cancer Immunology, Immunotherapy | 2018 |
The Pharmacology of T Cell Therapies
MC Milone, VG Bhoj |
Molecular Therapy — Methods & Clinical Development | 2018 |
Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma
CE Brown, B Aguilar, R Starr, X Yang, WC Chang, L Weng, B Chang, A Sarkissian, A Brito, JF Sanchez, JR Ostberg, M DApuzzo, B Badie, ME Barish, SJ Forman |
Molecular Therapy | 2018 |
Receptor-Targeted Glial Brain Tumor Therapies
P Sharma, W Debinski |
International journal of molecular sciences | 2018 |
Chimeric antigen receptor–modified T cells: CD19 and the road beyond
AI Salter, MJ Pont, SR Riddell |
Blood | 2018 |
Defining success with cellular therapeutics: the current landscape for clinical end point and toxicity analysis:
LS Kean |
Blood | 2018 |
CD19 Chimeric Antigen Receptor T Cells From Patients With Chronic Lymphocytic Leukemia Display an Elevated IFN-γ Production Profile:
I Magalhaes, I Kalland, JN Kochenderfer, A Österborg, M Uhlin, J Mattsson |
Journal of immunotherapy (Hagerstown, Md. : 1997) | 2018 |
Preclinical Optimization of a CD20-specific Chimeric Antigen Receptor Vector and Culture Conditions:
SY Lee, P Olsen, DH Lee, AL Kenoyer, LE Budde, S OSteen, DJ Green, S Heimfeld, MC Jensen, SR Riddell, OW Press, BG Till |
Journal of immunotherapy (Hagerstown, Md. : 1997) | 2018 |
Th9 Cells Represent a Unique Subset of CD4 + T Cells Endowed with the Ability to Eradicate Advanced Tumors
Y Lu, Q Wang, G Xue, E Bi, X Ma, A Wang, J Qian, C Dong, Q Yi |
Cancer Cell | 2018 |
Chimeric Antigen Receptor T Cell Therapy: Challenges to Bench-to-Bedside Efficacy
S Srivastava, SR Riddell |
Journal of immunology (Baltimore, Md. : 1950) | 2018 |
Chimeric Antigen Receptor T Cell-Mediated Neurotoxicity in Non-Human Primates
A Taraseviciute, V Tkachev, R Ponce, CJ Turtle, JM Snyder, HD Liggitt, D Myerson, L Gonzalez-Cuyar, A Baldessari, C English, A Yu, H Zheng, SN Furlan, DJ Hunt, V Hoglund, O Finney, H Brakke, BR Blazar, C Berger, S Riddell, R Gardner, LS Kean, MC Jensen |
Cancer Discovery | 2018 |
Characterization and clinical enrichment of HLA-C*07:02-restricted Cytomegalovirus-specific CD8+ T cells
F Schlott, D Steubl, S Ameres, A Moosmann, S Dreher, U Heemann, V Hösel, DH Busch, M Neuenhahn, M Nevels |
PloS one | 2018 |
Efficient Enrichment of Gene-Modified Primary T Cells via CCR5-Targeted Integration of Mutant Dihydrofolate Reductase
B Paul, GS Ibarra, N Hubbard, T Einhaus, A Astrakhan, DJ Rawlings, HP Kiem, CW Peterson |
Molecular Therapy — Methods & Clinical Development | 2018 |
Expansion of Gammadelta T Cells from Cord Blood: A Therapeutical Possibility
S Berglund, A Gaballa, P Sawaisorn, B Sundberg, M Uhlin |
Stem Cells International | 2018 |
CRISPR therapeutic tools for complex genetic disorders and cancer (Review)
S Baliou, M Adamaki, A Kyriakopoulos, D Spandidos, M Panagiotidis, I Christodoulou, V Zoumpourlis |
International journal of oncology | 2018 |
Cytomegalovirus infection and progressive differentiation of effector-memory T cells
IN Pardieck, G Beyrend, A Redeker, R Arens |
F1000Research | 2018 |
Efficient magnetic enrichment of antigen-specific T cells by engineering particle properties
JW Hickey, AY Isser, FP Vicente, SB Warner, HQ Mao, JP Schneck |
Biomaterials | 2018 |
Chimeric Antigen Receptors Based on Low Affinity Mutants of FcεRI Re-direct T Cell Specificity to Cells Expressing Membrane IgE
DE Ward, BL Fay, A Adejuwon, H Han, Z Ma |
Frontiers in immunology | 2018 |
Virus-Specific T Cells: Current and Future Use in Primary Immunodeficiency Disorders
KM Harris, BJ Davila, CM Bollard, MD Keller |
The Journal of Allergy and Clinical Immunology: In Practice | 2018 |
Cell‐Templated Silica Microparticles with Supported Lipid Bilayers as Artificial Antigen‐Presenting Cells for T Cell Activation
BR Olden, CR Perez, AL Wilson, II Cardle, YS Lin, B Kaehr, JA Gustafson, MC Jensen, SH Pun |
Advanced Healthcare Materials | 2018 |
Eomesodermin driven IL-10 production in effector CD8+ T cells promotes a memory phenotype
J Reiser, K Sadashivaiah, A Furusawa, A Banerjee, N Singh |
Cellular Immunology | 2018 |
T-cell functionality testing is highly relevant to developing novel immuno-tracers monitoring T cells in the context of immunotherapies and revealed CD7 as an attractive target
KE Mayer, S Mall, N Yusufi, D Gosmann, K Steiger, L Russelli, H de Oliviera Bianchi, S Audehm, R Wagner, E Bräunlein, A Stelzl, F Bassermann, W Weichert, W Weber, M Schwaiger, C D'Alessandria, AM Krackhardt |
Theranostics | 2018 |
CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia
S Vairy, JL Garcia, P Teira, H Bittencourt |
Drug design, development and therapy | 2018 |
Specific Adoptive T-Cell Therapy for Viral and Fungal Infections
Lum LG, Bollard CM |
2018 | |
Th17 cells are refractory to senescence retaining robust antitumor activity after long-term ex vivo expansion
Jacob Bowers, Michelle H. Nelson, Kinga Majchrzak, Stefanie Bailey, Barbel Rohrer, Andrew Kaiser, Carl Atkinson, Luca Gattinoni, Chrystal Paulos |
JCI Insight | 2017 |
Pharmacologic inhibition of β-catenin and PI3Kδ paradoxically expands precursor Th17 cells with heightened stemness and antitumor activity
Kinga Majchrzak, Michelle H. Nelson, Jacob Bowers, Stefanie Bailey, Megan Meek, John Wrangle, Juan Varela, Mark Rubinstein, zihai Li, Richard Himes, Sherine Chan, Chrystal Paulos |
JCI Insight | 2017 |
Fine-tuning the CAR spacer improves T-cell potency
N Watanabe, P Bajgain, S Sukumaran, S Ansari, HE Heslop, CM Rooney, MK Brenner, AM Leen, JF Vera |
OncoImmunology | 2017 |
PI3Kδ Inhibition Enhances the Antitumor Fitness of Adoptively Transferred CD8+ T Cells
JS Bowers, K Majchrzak, MH Nelson, BA Aksoy, MM Wyatt, AS Smith, SR Bailey, LR Neal, JE Hammerbacher, CM Paulos |
Frontiers in immunology | 2017 |
Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody–Activated Chimeric Antigen Receptor–Modified T Cells
M Schmueck-Henneresse, B Omer, T Shum, H Tashiro, M Mamonkin, N Lapteva, S Sharma, L Rollins, G Dotti, P Reinke, HD Volk, CM Rooney |
Journal of immunology (Baltimore, Md. : 1950) | 2017 |
Multifaceted Role of BTLA in the Control of CD8 + T-cell Fate after Antigen Encounter
K Ritthipichai, CL Haymaker, M Martinez, A Aschenbrenner, X Yi, M Zhang, C Kale, LM Vence, J Roszik, Y Hailemichael, WW Overwijk, N Varadarajan, R Nurieva, LG Radvanyi, P Hwu, C Bernatchez |
Clinical cancer research | 2017 |
T memory stem cells in health and disease
L Gattinoni, DE Speiser, M Lichterfeld, C Bonini |
Nature Medicine | 2017 |
Systematic evaluation of immune regulation and modulation
DF Stroncek, LH Butterfield, MA Cannarile, MV Dhodapkar, TF Greten, JC Grivel, DR Kaufman, HH Kong, F Korangy, PP Lee, F Marincola, S Rutella, JC Siebert, G Trinchieri, B Seliger |
Journal for ImmunoTherapy of Cancer | 2017 |
Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective
I Rivière, M Sadelain |
Molecular Therapy | 2017 |
Therapeutic T cell engineering
M Sadelain, I Rivière, S Riddell |
Nature | 2017 |
CARs: Synthetic Immunoreceptors for Cancer Therapy and Beyond
ZN Chang, YY Chen |
Trends in Molecular Medicine | 2017 |
Building upon the success of CART19: chimeric antigen receptor T cells for hematologic malignancies
A Rotolo, A Karadimitris, M Ruella |
Leukemia & Lymphoma | 2017 |
Development of T cell immunotherapy for hematopoietic stem cell transplantation recipients at risk of leukemia relapse
RG Dossa, T Cunningham, D Sommermeyer, I Medina-Rodriguez, MA Biernacki, K Foster, M Bleakley |
Blood | 2017 |
Immunotherapy of cancer: targeting cancer during active disease or during dormancy?
SA Shah, M Zarei, SH Manjili, G Guruli, XY Wang, MH Manjili |
Immunotherapy | 2017 |
CCR7+ selected gene-modified T cells maintain a central memory phenotype and display enhanced persistence in peripheral blood in vivo
G Kueberuwa, H Gornall, EM Alcantar-Orozco, D Bouvier, ZA Kapacee, RE Hawkins, DE Gilham |
Journal for ImmunoTherapy of Cancer | 2017 |
Ex vivo Akt inhibition promotes the generation of potent CD19CAR T cells for adoptive immunotherapy
R Urak, M Walter, L Lim, CL Wong, LE Budde, S Thomas, SJ Forman, X Wang |
Journal for ImmunoTherapy of Cancer | 2017 |
Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir
JL Riley, LJ Montaner |
The Journal of Infectious Diseases | 2017 |
Tracking the fate and origin of clinically relevant adoptively transferred CD8 + T cells in vivo
AG Chapuis, C Desmarais, R Emerson, TM Schmitt, KC Shibuya, IP Lai, F Wagener, J Chou, IM Roberts, DG Coffey, EH Warren, H Robins, PD Greenberg, C Yee |
Science Immunology | 2017 |
Curtailed T-cell activation curbs effector differentiation and generates CD8 + T cells with a naturally-occurring memory stem cell phenotype
V Zanon, K Pilipow, E Scamardella, FD Paoli, GD Simone, DA Price, AM Usatorre, P Romero, D Mavilio, A Roberto, E Lugli |
European Journal of Immunology | 2017 |
Predictive factors of the tumor immunological microenvironment for long-term follow-up in early stage breast cancer
M Okabe, U Toh, N Iwakuma, S Saku, M Akashi, Y Kimitsuki, N Seki, A Kawahara, E Ogo, K Itoh, Y Akagi |
Cancer Science | 2017 |
Differential cytokine withdrawal-induced death sensitivity of effector T cells derived from distinct human CD8+ memory subsets
SE Larsen, K Voss, ED Laing, AL Snow |
Cell Death Discovery | 2017 |
Considerations in T Cell Therapy Product Development for B Cell Leukemia and Lymphoma Immunotherapy
AD Fesnak, PJ Hanley, BL Levine |
Current Hematologic Malignancy Reports | 2017 |
Anti-CD 19 and anti-CD 20 CAR-modified T cells for B-cell malignancies: a systematic review and meta-analysis
IB Riaz, U Zahid, MU Kamal, M Husnain, A McBride, A Hua, AA Hamadani, L George, A Zeeshan, QA Sipra, A Raina, B Rahman, S Puvvada, F Anwer |
Immunotherapy | 2017 |
Different death destinies: relative apoptosis sensitivity shapes the human effector CD8+ T-cell response derived from distinct memory subsets
AL Snow, SE Larsen |
Cell Death and Disease | 2017 |
Polyfunctional response by ImmTAC (IMCgp100) redirected CD8 + and CD4 + T cells
C Boudousquie, G Bossi, JM Hurst, KA Rygiel, BK Jakobsen, NJ Hassan |
Immunology | 2017 |
Robust Production of Cytomegalovirus pp65-Specific T Cells Using a Fully Automated IFN-γ Cytokine Capture System
N Kim, YS Nam, KI Im, JY Lim, YW Jeon, Y Song, JW Lee, SG Cho |
Transfusion Medicine and Hemotherapy | 2017 |
特异性人工抗原提呈细胞体外激活CD19嵌合抗原受体T细胞的构建
|
2017 | |
CD19 CAR-T cells of defined CD4+:CD8+ composition for adult B-cell ALL
Cameron Turtle, Laïla-Aïcha Hanafi, Carolina Berger, Theodore Gooley, Sindhu Cherian, Michael Hudecek, Daniel Sommermeyer, Katherine Melville, Pender Barbara, Tanya Budiarto, Emily Robinson, Natalia Steevens, Colette Chaney, Lorinda Soma, Xueyan Chen, Cecilia Yeung, Brent Wood, Daniel Li, Jianhong Cao, Shelly Heimfeld, Michael C. Jensen, Stanley R. Riddell, David Maloney |
Journal of Clinical Investigation | 2016 |
BET bromodomain inhibition generates superior T cells for adoptive immunotherapy
Yuki Kagoya, Munehide Nakatsugawa, Yuki Yamashita, Toshiki Ochi, Tingxi Guo, Mark Anczurowski, Kayoko Saso, Marcus Butler, Cheryl Arrowsmith, Naoto Hirano |
Journal of Clinical Investigation | 2016 |
Heterodimeric IL15 Treatment Enhances Tumor Infiltration, Persistence, and Effector Functions of Adoptively Transferred Tumor-specific T Cells in the Absence of Lymphodepletion
SS Ng, BA Nagy, SM Jensen, X Hu, C Alicea, BA Fox, BK Felber, C Bergamaschi, GN Pavlakis |
Clinical cancer research | 2016 |
Role of memory T cell subsets for adoptive immunotherapy
DH Busch, SP Fräßle, D Sommermeyer, VR Buchholz, SR Riddell |
Seminars in Immunology | 2016 |
Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
LV Hurton, H Singh, AM Najjar, KC Switzer, T Mi, S Maiti, S Olivares, B Rabinovich, H Huls, MA Forget, V Datar, P Kebriaei, DA Lee, RE Champlin, LJ Cooper |
Proceedings of the National Academy of Sciences | 2016 |
Driving gene-engineered T cell immunotherapy of cancer
LA Johnson, CH June |
Cell Research | 2016 |
Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination
A Redeker, R Arens |
Frontiers in immunology | 2016 |
Marrow-Infiltrating Lymphocytes – Role in Biology and Cancer Therapy
I Borrello, KA Noonan |
Frontiers in immunology | 2016 |
Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications
M Reis, J Ogonek, M Qesari, NM Borges, L Nicholson, L Preußner, AM Dickinson, X Wang, EM Weissinger, A Richter |
Frontiers in immunology | 2016 |
Constitutive Lck Activity Drives Sensitivity Differences between CD8+ Memory T Cell Subsets
D Moogk, S Zhong, Z Yu, I Liadi, W Rittase, V Fang, J Dougherty, A Perez-Garcia, I Osman, C Zhu, N Varadarajan, NP Restifo, AB Frey, M Krogsgaard |
Journal of immunology (Baltimore, Md. : 1950) | 2016 |
Improving therapy of chronic lymphocytic leukemia with chimeric antigen receptor T cells
JA Fraietta, RD Schwab, MV Maus |
Seminars in Oncology | 2016 |
Reprogramming of Melanoma Tumor-Infiltrating Lymphocytes to Induced Pluripotent Stem Cells
H Saito, K Okita, N Fusaki, MS Sabel, AE Chang, F Ito |
Stem Cells International | 2016 |
Soluble and membrane-bound interleukin (IL)-15 R α /IL-15 complexes mediate proliferation of high-avidity central memory CD8 + T cells for adoptive immunotherapy of cancer and infections: IL-15Rα/IL-15 & memory T cell avidity
AN Hasan, A Selvakumar, E Shabrova, XR Liu, F Afridi, G Heller, I Riviere, M Sadelain, B Dupont, RJ O'Reilly |
Clinical & Experimental Immunology | 2016 |
T Cell Maturation Stage Prior to and During GMP Processing Informs on CAR T Cell Expansion in Patients
Y Klaver, SC van Steenbergen, S Sleijfer, R Debets, CH Lamers |
Frontiers in immunology | 2016 |
CMV-Specific CD8 T Cell Differentiation and Localization: Implications for Adoptive Therapies
CJ Smith, M Quinn, CM Snyder |
Frontiers in immunology | 2016 |
Adoptive Transfer of Engineered Rhesus Simian Immunodeficiency Virus-Specific CD8 + T Cells Reduces the Number of Transmitted/Founder Viruses Established in Rhesus Macaques
VI Ayala, MT Trivett, EV Barsov, S Jain, M Piatak, CM Trubey, WG Alvord, E Chertova, JD Roser, J Smedley, A Komin, BF Keele, C Ohlen, DE Ott, G Silvestri |
Journal of virology | 2016 |
Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL
X Wang, LL Popplewell, JR Wagner, A Naranjo, MS Blanchard, MR Mott, AP Norris, CW Wong, RZ Urak, WC Chang, SK Khaled, T Siddiqi, LE Budde, J Xu, B Chang, N Gidwaney, SH Thomas, LJ Cooper, SR Riddell, CE Brown, MC Jensen, SJ Forman |
Blood | 2016 |
A short CD3/CD28 costimulation combined with IL-21 enhance the generation of human memory stem T cells for adoptive immunotherapy
C Alvarez-Fernández, L Escribà-Garcia, S Vidal, J Sierra, J Briones |
Journal of Translational Medicine | 2016 |
Immunotherapy of non-Hodgkins lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells
CJ Turtle, LA Hanafi, C Berger, M Hudecek, B Pender, E Robinson, R Hawkins, C Chaney, S Cherian, X Chen, L Soma, B Wood, D Li, S Heimfeld, SR Riddell, DG Maloney |
Science Translational Medicine | 2016 |
Clinical manufacturing of CAR T cells: foundation of a promising therapy
X Wang, I Rivière |
Molecular Therapy — Oncolytics | 2016 |
Modulation of mTOR Signalling Triggers the Formation of Stem Cell-like Memory T Cells
G Scholz, C Jandus, L Zhang, C Grandclément, IC Lopez-Mejia, C Soneson, M Delorenzi, L Fajas, W Held, O Dormond, P Romero |
EBioMedicine | 2016 |
Cytomegalovirus and immunotherapy: opportunistic pathogen, novel target for cancer and a promising vaccine vector
M Quinn, DA Erkes, CM Snyder |
Immunotherapy | 2016 |
Naïve CD8+ T cell derived tumor-specific cytotoxic effectors as a potential remedy for overcoming TGF-β immunosuppression in the tumor microenvironment
HH Nguyen, T Kim, SY Song, S Park, HH Cho, SH Jung, JS Ahn, HJ Kim, JJ Lee, HO Kim, JH Cho, DH Yang |
Scientific Reports | 2016 |
Virus-specific T-cell banks for 'off the shelf' adoptive therapy of refractory infections
RJ O'Reilly, S Prockop, AN Hasan, G Koehne, E Doubrovina |
Bone Marrow Transplantation | 2016 |
T-cell therapies for HIV: Preclinical successes and current clinical strategies
S Patel, RB Jones, DF Nixon, CM Bollard |
Cytotherapy | 2016 |
CAR T Cell Therapy: A Game Changer in Cancer Treatment
H Almåsbak, T Aarvak, MC Vemuri |
Journal of Immunology Research | 2016 |
T cells for viral infections after allogeneic hematopoietic stem cell transplant
CM Bollard, HE Heslop |
Blood | 2016 |
Different Subsets of T Cells, Memory, Effector Functions, and CAR-T Immunotherapy
V Golubovskaya, L Wu |
Cancers | 2016 |
Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ Tumors
R Thokala, S Olivares, T Mi, S Maiti, D Deniger, H Huls, H Torikai, H Singh, RE Champlin, T Laskowski, G McNamara, LJ Cooper, D Unutmaz |
PloS one | 2016 |
Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
Hanren Dai, Yao Wang, Xuechun Lu, Weidong Han |
JNCI Journal of the National Cancer Institute | 2016 |
L1 Cell Adhesion Molecule-Specific Chimeric Antigen Receptor-Redirected Human T Cells Exhibit Specific and Efficient Antitumor Activity against Human Ovarian Cancer in Mice
H Hong, CE Brown, JR Ostberg, SJ Priceman, WC Chang, L Weng, P Lin, MT Wakabayashi, MC Jensen, SJ Forman, N Gangopadhyay |
PloS one | 2016 |
Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?
V Dutoit, D Migliorini, PY Dietrich, PR Walker |
Frontiers in Oncology | 2016 |
Technical Considerations for the Generation of Adoptively Transferred T Cells in Cancer Immunotherapy
A Visioni, J Skitzki |
Cancers | 2016 |
Immunological quality and performance of tumor vessel-targeting CAR-T cells prepared by mRNA-EP for clinical research
K Inoo, R Inagaki, K Fujiwara, S Sasawatari, T Kamigaki, S Nakagawa, N Okada |
Molecular Therapy - Oncolytics | 2016 |
Tumor-infiltrating lymphocytes (TILs) from patients with glioma
Z Liu, Q Meng, J Bartek, T Poiret, O Persson, L Rane, E Rangelova, C Illies, IH Peredo, X Luo, MV Rao, RA Robertson, E Dodoo, M Maeurer |
OncoImmunology | 2016 |
Quorum-like behavior between T-cell subsets enhances differentiation impairing cellular immunotherapy
Christopher A. Klebanoff, Christopher Scott, Anthony Leonardi, Tori Yamamoto, Anthony Cruz, Claudia Ouyang, Madhu Ramaswamy, Rahul Roychoudhuri, Yun Ji, Robert Eil, Madhusudhanan Sukumar, Joseph G. Crompton, Douglas C. Palmer, Zachary Borman, David Clever, Stacy K. Thomas, Shashank Patel, Zhiya Yu, Pawel Muranski, Hui Liu, Ena Wang, Francesco Marincola, Alena Gros, Luca Gattinoni, Steven Rosenberg, Richard Siegel, Nicholas Restifo |
Journal of Clinical Investigation | 2015 |
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo
D Sommermeyer, M Hudecek, PL Kosasih, T Gogishvili, DG Maloney, CJ Turtle, SR Riddell |
Leukemia | 2015 |
T-cell receptor gene therapy - ready to go viral?
T Karpanen, J Olweus |
Molecular Oncology | 2015 |
CMV-specific T cells generated from naive T cells recognize atypical epitopes and may be protective in vivo
PJ Hanley, JJ Melenhorst, S Nikiforow, P Scheinberg, JW Blaney, G Demmler-Harrison, CR Cruz, S Lam, RA Krance, KS Leung, CA Martinez, H Liu, DC Douek, HE Heslop, CM Rooney, EJ Shpall, AJ Barrett, JR Rodgers, CM Bollard |
Science Translational Medicine | 2015 |
Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma
KA Noonan, CA Huff, J Davis, MV Lemas, S Fiorino, J Bitzan, A Ferguson, A Emerling, L Luznik, W Matsui, J Powell, E Fuchs, GL Rosner, C Epstein, L Rudraraju, RF Ambinder, RJ Jones, D Pardoll, I Borrello |
Science Translational Medicine | 2015 |
Generation of memory T cells for adoptive transfer using clinical-grade anti-CD62L magnetic beads
S Verfuerth, PS Sousa, L Beloki, M Murray, MD Peters, S Mackinnon, MW Lowdell, R Chakraverty, ER Samuel |
Bone Marrow Transplantation | 2015 |
Chimeric Antigen Receptor- and TCR-Modified T Cells Enter Main Street and Wall Street
DM Barrett, SA Grupp, CH June |
Journal of immunology (Baltimore, Md. : 1950) | 2015 |
Towards a commercial process for the manufacture of genetically modified T cells for therapy
AD Kaiser, M Assenmacher, B Schröder, M Meyer, R Orentas, U Bethke, B Dropulic |
Cancer Gene Therapy | 2015 |
Adoptive cell transfer as personalized immunotherapy for human cancer
SA Rosenberg, NP Restifo |
Science | 2015 |
Genetically modified T cells in cancer therapy: opportunities and challenges
M Sharpe, N Mount |
Disease models & mechanisms | 2015 |
Synthetic biology in cell-based cancer immunotherapy
D Chakravarti, WW Wong |
Trends in Biotechnology | 2015 |
Comparison of Naïve and Central Memory Derived CD8 + Effector Cell Engraftment Fitness and Function Following Adoptive Transfer
X Wang, CL Wong, R Urak, E Taus, B Aguilar, WC Chang, A Mardiros, LE Budde, CE Brown, C Berger, SJ Forman, MC Jensen |
OncoImmunology | 2015 |
Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia
H Dai, W Zhang, X Li, Q Han, Y Guo, Y Zhang, Y Wang, C Wang, F Shi, Y Zhang, M Chen, K Feng, Q Wang, H Zhu, X Fu, S Li, W Han |
OncoImmunology | 2015 |
Early transduction produces highly functional chimeric antigen receptor-modified virus-specific T-cells with central memory markers: a Production Assistant for Cell Therapy (PACT) translational application
J Sun, LE Huye, N Lapteva, M Mamonkin, M Hiregange, B Ballard, O Dakhova, D Raghavan, AG Durett, SK Perna, B Omer, LA Rollins, AM Leen, JF Vera, G Dotti, AP Gee, MK Brenner, DG Myers, CM Rooney |
Journal for ImmunoTherapy of Cancer | 2015 |
Chimeric antigen receptors and bispecific antibodies to retarget T cells in pediatric oncology: CAR T Cells and BsAbs in Pediatric Oncology
M Suzuki, KJ Curran, NK Cheung |
Pediatric Blood & Cancer | 2015 |
Seatbelts in CAR therapy: How Safe Are CARS?
K Minagawa, X Zhou, S Mineishi, AD Stasi |
Pharmaceuticals (Basel, Switzerland) | 2015 |
Identification and selective expansion of functionally superior T cells expressing chimeric antigen receptors
ZN Chang, PA Silver, YY Chen |
Journal of Translational Medicine | 2015 |
Long-term Outcome of Extranodal NK/T Cell Lymphoma Patients Treated With Postremission Therapy Using EBV LMP1 and LMP2a-specific CTLs
SG Cho, N Kim, HJ Sohn, SK Lee, ST Oh, HJ Lee, HI Cho, HW Yim, SE Jung, G Park, JH Oh, BO Choi, SW Kim, SW Kim, NG Chung, JW Lee, YS Hong, TG Kim |
Molecular Therapy | 2015 |
CMVpp65 Vaccine Enhances the Antitumor Efficacy of Adoptively Transferred CD19-Redirected CMV-Specific T Cells
X Wang, CW Wong, R Urak, A Mardiros, LE Budde, WC Chang, SH Thomas, CE Brown, CL Rosa, DJ Diamond, MC Jensen, R Nakamura, JA Zaia, SJ Forman |
Clinical cancer research | 2015 |
Broad spectrum antiviral T cells for viral complications after hematopoietic stem cell transplantation
Britta Maecker-Kolhoff, Britta Eiz-Vesper |
Annals of translational medicine | 2015 |
The next step towards GMP-grade production of engineered immune cells
GJ Kierkels, T Straetemans, MA de Witte, J Kuball |
OncoImmunology | 2015 |
Smart CARs engineered for cancer immunotherapy:
SJ Priceman, SJ Forman, CE Brown |
Current Opinion in Oncology | 2015 |
T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma
IM Stromnes, TM Schmitt, A Hulbert, JS Brockenbrough, HN Nguyen, C Cuevas, AM Dotson, X Tan, JL Hotes, PD Greenberg, SR Hingorani |
Cancer Cell | 2015 |
Chimeric Antigen Receptor T-Cells: New Approaches to Improve Their Efficacy and Reduce Toxicity
MV Maus, DJ Powell |
The Cancer Journal | 2015 |
Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors
H Karlsson, E Svensson, C Gigg, M Jarvius, U Olsson-Strömberg, B Savoldo, G Dotti, A Loskog, K Tasken |
PloS one | 2015 |
New Strategies in Engineering T-cell Receptor Gene-Modified T cells to More Effectively Target Malignancies
TM Schmitt, IM Stromnes, AG Chapuis, PD Greenberg |
Clinical cancer research | 2015 |
Memory T Cells Specific for Murine Cytomegalovirus Re-Emerge after Multiple Challenges and Recapitulate Immunity in Various Adoptive Transfer Scenarios
M Quinn, H Turula, M Tandon, B Deslouches, T Moghbeli, CM Snyder |
Journal of immunology (Baltimore, Md. : 1950) | 2015 |
Chimeric Antigen Receptor Therapy for Cancer
DM Barrett, N Singh, DL Porter, SA Grupp, CH June |
Annual Review of Medicine | 2014 |
Engineering Human Peripheral Blood Stem Cell Grafts that Are Depleted of Naïve T Cells and Retain Functional Pathogen-Specific Memory T Cells
M Bleakley, S Heimfeld, LA Jones, C Turtle, D Krause, SR Riddell, W Shlomchik |
Biology of Blood and Marrow Transplantation | 2014 |
Advances in Experimental Medicine and Biology
C DeRenzo, S Gottschalk |
Advances in experimental medicine and biology | 2014 |
Promoting Thiol Expression Increases the Durability of Antitumor T-cell Functions
P Kesarwani, AA Al-Khami, G Scurti, K Thyagarajan, N Kaur, S Husain, Q Fang, OS Naga, P Simms, G Beeson, C Voelkel-Johnson, E Garrett-Mayer, CC Beeson, MI Nishimura, S Mehrotra |
Cancer research | 2014 |
Elimination of Progressive Mammary Cancer by Repeated Administrations of Chimeric Antigen Receptor-Modified T Cells
A Globerson-Levin, T Waks, Z Eshhar |
Molecular Therapy | 2014 |
Engineered T cells for cancer treatment
U Anurathapan, AM Leen, MK Brenner, JF Vera |
Cytotherapy | 2014 |
Manufacture of Gene-Modified Human T-Cells with a Memory Stem/Central Memory Phenotype
R Gomez-Eerland, B Nuijen, B Heemskerk, N Rooij, JH van Berg, JH Beijnen, W Uckert, P Kvistborg, TN Schumacher, JB Haanen, A Jorritsma |
Human Gene Therapy Methods | 2014 |
Relation of clinical culture method to T-cell memory status and efficacy in xenograft models of adoptive immunotherapy
DM Barrett, N Singh, X Liu, S Jiang, CH June, SA Grupp, Y Zhao |
Cytotherapy | 2014 |
Allogeneic lymphocyte-licensed DCs expand T cells with improved antitumor activity and resistance to oxidative stress and immunosuppressive factors
C Jin, D Yu, V Hillerdal, AC Wallgren, A Karlsson-Parra, M Essand |
Molecular Therapy — Methods & Clinical Development | 2014 |
Prostaglandin E2 promotes survival of naive UCB T cells via the Wnt/β-catenin pathway and alters immune reconstitution after UCBT
L Li, HT Kim, A Nellore, N Patsoukis, V Petkova, S McDonough, I Politikos, S Nikiforow, R Soiffer, JH Antin, K Ballen, C Cutler, J Ritz, VA Boussiotis |
Blood Cancer Journal | 2014 |
Cell-based strategies to manage leukemia relapse: efficacy and feasibility of immunotherapy approaches
A Rambaldi, E Biagi, C Bonini, A Biondi, M Introna |
Leukemia | 2014 |
Antigen-Specific Culture of Memory-like CD8 T Cells for Adoptive Immunotherapy
AJ Litterman, DM Zellmer, RS LaRue, SC Jameson, DA Largaespada |
Cancer immunology research | 2014 |
Immunologic special forces: anti-pathogen cytotoxic T-lymphocyte immunotherapy following hematopoietic stem cell transplantation
M Keller, C Bollard |
ImmunoTargets and Therapy | 2014 |
Adoptive Immunotherapy for Hematological Malignancies Using T Cells Gene-Modified to Express Tumor Antigen-Specific Receptors
H Fujiwara |
Pharmaceuticals (Basel, Switzerland) | 2014 |
Therapeutic targeting of naturally presented myeloperoxidase-derived HLA peptide ligands in myeloid leukemia cells by TCR-transgenic T cells
R Klar, S Schober, M Rami, S Mall, J Merl, SM Hauck, M Ueffing, A Admon, J Slotta-Huspenina, M Schwaiger, S Stevanović, RA Oostendorp, DH Busch, C Peschel, AM Krackhardt |
Leukemia Supplements | 2014 |
Progress and prospects for engineered T cell therapies
W Qasim, AJ Thrasher |
British Journal of Haematology | 2014 |
Adoptive Immunotherapy for Cancer or Viruses
MV Maus, JA Fraietta, BL Levine, M Kalos, Y Zhao, CH June |
Annual Review of Immunology | 2014 |
Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15
Y Xu, M Zhang, CA Ramos, A Durett, E Liu, O Dakhova, H Liu, CJ Creighton, AP Gee, HE Heslop, CM Rooney, B Savoldo, G Dotti |
Blood | 2014 |
Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells
M Wölfl, PD Greenberg |
Nature Protocols | 2014 |
Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy
B Thaci, CE Brown, E Binello, K Werbaneth, P Sampath, S Sengupta |
Neuro-Oncology | 2014 |
A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells
M Cartellieri, S Koristka, C Arndt, A Feldmann, S Stamova, M Bonin, K Töpfer, T Krüger, M Geib, I Michalk, A Temme, M Bornhäuser, D Lindemann, G Ehninger, MP Bachmann |
PloS one | 2014 |
Homeostatic expansion as a barrier to lymphocyte depletion strategies:
NA Zwang, LA Turka |
Current Opinion in Organ Transplantation | 2014 |
The role of CD4+ T cells in BKV-specific T cell immunity
BJ Weist, M Schmueck, H Fuehrer, A Sattler, P Reinke, N Babel |
Medical Microbiology and Immunology | 2014 |
Anticancer Tc9 cells
Y Lu, Q Wang, Q Yi |
OncoImmunology | 2014 |
Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects
H Shi, M Sun, L Liu, Z Wang |
Molecular Cancer | 2014 |
Chimeric Antigen Receptors With Mutated IgG4 Fc Spacer Avoid Fc Receptor Binding and Improve T Cell Persistence and Antitumor Efficacy
M Jonnalagadda, A Mardiros, R Urak, X Wang, LJ Hoffman, A Bernanke, WC Chang, W Bretzlaff, R Starr, S Priceman, JR Ostberg, SJ Forman, CE Brown |
Molecular Therapy | 2014 |
Advances in T-cell therapy for ALL
SA Grupp |
Best Practice & Research Clinical Haematology | 2014 |
Adoptive Therapy With Chimeric Antigen Receptor–Modified T Cells of Defined Subset Composition:
SR Riddell, D Sommermeyer, C Berger, LS Liu, A Balakrishnan, A Salter, M Hudecek, DG Maloney, CJ Turtle |
The Cancer Journal | 2014 |
CD19-CAR Trials:
CA Ramos, B Savoldo, G Dotti |
The Cancer Journal | 2014 |
Metabolic Engineering of Salmonella Vaccine Bacteria To Boost Human V 2V 2 T Cell Immunity
G Workalemahu, H Wang, KJ Puan, MH Nada, T Kuzuyama, BD Jones, C Jin, CT Morita |
Journal of immunology (Baltimore, Md. : 1950) | 2014 |
Safety of Targeting ROR1 in Primates with Chimeric Antigen Receptor-Modified T Cells
C Berger, D Sommermeyer, M Hudecek, M Berger, A Balakrishnan, PJ Paszkiewicz, PL Kosasih, C Rader, SR Riddell |
Cancer immunology research | 2014 |
The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity
M Hudecek, D Sommermeyer, PL Kosasih, A Silva-Benedict, L Liu, C Rader, MC Jensen, SR Riddell |
Cancer immunology research | 2014 |
Chemokines as Novel and Versatile Reagents for Flow Cytometry and Cell Sorting
ML le Brocq, AR Fraser, G Cotton, K Woznica, CV McCulloch, KD Hewit, CS McKimmie, RJ Nibbs, JD Campbell, GJ Graham |
Journal of immunology (Baltimore, Md. : 1950) | 2014 |
Nature Biotechnology's academic spinouts of 2013.
Bouchie A, Allison M, Webb S, DeFrancesco L |
Nature Biotechnology | 2014 |
A cytokine cocktail directly modulates the phenotype of DC-enriched anti-tumor T cells to convey potent anti-tumor activities in a murine model
S Yang, GE Archer, CE Flores, DA Mitchell, JH Sampson |
Cancer Immunology, Immunotherapy | 2013 |
Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy
JG Crompton, M Sukumar, NP Restifo |
Immunological Reviews | 2013 |
Impact of T cell selection methods in the success of clinical adoptive immunotherapy
N Ramírez, L Beloki, M Ciaúrriz, M Rodríguez-Calvillo, D Escors, C Mansilla, E Bandrés, E Olavarría |
Cellular and Molecular Life Sciences | 2013 |
Re-adapting T cells for cancer therapy: from mouse models to clinical trials
IM Stromnes, TM Schmitt, AG Chapuis, SR Hingorani, PD Greenberg |
Immunological Reviews | 2013 |
Potential limitations of the NSG humanised mouse as a model system to optimise engineered human T cell therapy for cancer
EM Alcantar-Orozco, H Gornall, V Baldan, RE Hawkins, DE Gilham |
Human Gene Therapy Methods | 2013 |
Clinical-scale selection and viral transduction of human naïve and central memory CD8+ T cells for adoptive cell therapy of cancer patients
A Casati, A Varghaei-Nahvi, SA Feldman, M Assenmacher, SA Rosenberg, ME Dudley, A Scheffold |
Cancer Immunology, Immunotherapy | 2013 |
A practical approach to immunotherapy of hepatocellular carcinoma using T cells redirected against hepatitis B virus
S Koh, N Shimasaki, R Suwanarusk, ZZ Ho, A Chia, N Banu, SW Howland, AS Ong, AJ Gehring, H Stauss, L Renia, M Sällberg, D Campana, A Bertoletti |
Molecular Therapy — Nucleic Acids | 2013 |
Hematopoietic stem cells for cancer immunotherapy
E Gschweng, SD Oliveira, DB Kohn |
Immunological Reviews | 2013 |
Human cell-based artificial antigen-presenting cells for cancer immunotherapy
MO Butler, N Hirano |
Immunological Reviews | 2013 |
Chimeric antigen receptors (CARs) from bench-to-bedside
B Savoldo, G Dotti |
Immunology Letters | 2013 |
Rapamycin-resistant effector T-cell therapy
DH Fowler |
Immunological Reviews | 2013 |
Proliferation-linked apoptosis of adoptively transferred T cells after IL-15 administration in macaques
C Berger, M Berger, BC Beard, HP Kiem, TA Gooley, SR Riddell |
PloS one | 2013 |
Exploiting the curative potential of adoptive T-cell therapy for cancer
CS Hinrichs, SA Rosenberg |
Immunological Reviews | 2013 |
Efficient selection of genetically modified human T cells using methotrexate-resistant human dihydrofolate reductase
M Jonnalagadda, CE Brown, WC Chang, JR Ostberg, SJ Forman, MC Jensen |
Gene Therapy | 2013 |
Transferred WT1-Reactive CD8+ T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients
AG Chapuis, GB Ragnarsson, HN Nguyen, CN Chaney, JS Pufnock, TM Schmitt, N Duerkopp, IM Roberts, GL Pogosov, WY Ho, S Ochsenreither, M Wolfl, M Bar, JP Radich, C Yee, PD Greenberg |
Science Translational Medicine | 2013 |
Allelic Exclusion and Peripheral Reconstitution by TCR Transgenic T Cells Arising From Transduced Human Hematopoietic Stem/Progenitor Cells
F Giannoni, CL Hardee, J Wherley, E Gschweng, S Senadheera, ML Kaufman, R Chan, I Bahner, V Gersuk, X Wang, D Gjertson, D Baltimore, ON Witte, JS Economou, A Ribas, DB Kohn |
Molecular Therapy | 2013 |
Genetically engineered T cells for the treatment of cancer
M Essand, AS Loskog |
Journal of Internal Medicine | 2013 |
Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology
M Kalos, CH June |
Immunity | 2013 |
CD4 T-cell immunotherapy for chronic viral infections and cancer
AO Kamphorst, R Ahmed |
Immunotherapy | 2013 |
T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia
A Mardiros, CD Santos, T McDonald, CE Brown, X Wang, LE Budde, L Hoffman, B Aguilar, WC Chang, W Bretzlaff, B Chang, M Jonnalagadda, R Starr, JR Ostberg, MC Jensen, R Bhatia, SJ Forman |
Blood | 2013 |
TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu
A Kunert, T Straetemans, C Govers, C Lamers, R Mathijssen, S Sleijfer, R Debets |
Frontiers in immunology | 2013 |
T-cell therapies for HIV
S Lam, C Bollard |
Immunotherapy | 2013 |
Adoptive T-cell therapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific receptors
H Fujiwara |
International Journal of Hematology | 2013 |
Chimeric antigen receptor modified T cell therapy for B cell malignancies
CJ Turtle |
International Journal of Hematology | 2013 |
Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells
MC Jensen, SR Riddell |
Immunological Reviews | 2013 |
Genetically modified T cells for the treatment of malignant disease
A Wieczorek, L Uharek |
Transfusion Medicine and Hemotherapy | 2013 |
Genetically modified T cells to target glioblastoma
S Krebs, TG Rodríguez-Cruz, C Derenzo, S Gottschalk |
Frontiers in Oncology | 2013 |
Combining a CD20 chimeric antigen receptor and an inducible caspase 9 suicide switch to improve the efficacy and safety of T cell adoptive immunotherapy for lymphoma
LE Budde, C Berger, Y Lin, J Wang, X Lin, SE Frayo, SA Brouns, DM Spencer, BG Till, MC Jensen, SR Riddell, OW Press |
PloS one | 2013 |
Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges
EQ Han, X Li, C Wang, T Li, S Han |
Journal of Hematology & Oncology | 2013 |
Engineering human T cells for resistance to methotrexate and mycophenolate mofetil as an in vivo cell selection strategy
M Jonnalagadda, CE Brown, WC Chang, JR Ostberg, SJ Forman, MC Jensen |
PloS one | 2013 |
Sleeping beauty system to redirect T-cell specificity for human applications
SN Maiti, H Huls, H Singh, M Dawson, M Figliola, S Olivares, P Rao, YJ Zhao, A Multani, G Yang, L Zhang, D Crossland, S Ang, H Torikai, B Rabinovich, DA Lee, P Kebriaei, P Hackett, RE Champlin, LJ Cooper |
Journal of immunotherapy (Hagerstown, Md. : 1997) | 2013 |
Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry
B Eiz-Vesper, B Maecker-Kolhoff, R Blasczyk |
Frontiers in immunology | 2013 |
Regression of Metastatic Merkel Cell Carcinoma Following Transfer of Polyomavirus-Specific T Cells and Therapies Capable of Reinducing HLA Class-I
AG Chapuis, OK Afanasiev, JG Iyer, KG Paulson, U Parvathaneni, JH Hwang, I Lai, IM Roberts, HL Sloan, S Bhatia, KC Shibuya, T Gooley, C Desmarais, DM Koelle, C Yee, P Nghiem |
Cancer immunology research | 2013 |
Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins
CM Bollard, S Gottschalk, V Torrano, O Diouf, S Ku, Y Hazrat, G Carrum, C Ramos, L Fayad, EJ Shpall, B Pro, H Liu, MF Wu, D Lee, AM Sheehan, Y Zu, AP Gee, MK Brenner, HE Heslop, CM Rooney |
Journal of Clinical Oncology | 2013 |
Understanding the biology of ex vivo-expanded CD8 T cells for adoptive cell therapy: role of CD62L.
Díaz-Montero CM, Zidan AA, Pallin MF, Anagnostopoulos V, Salem ML, Wieder E, Komanduri K, Montero AJ, Lichtenheld MG |
Immunologic research | 2013 |
The stoichiometric production of IL-2 and IFN-γ mRNA defines memory T cells that can self-renew after adoptive transfer in humans
A Wang, S Chandran, SA Shah, Y Chiu, BC Paria, T Aghamolla, MM Alvarez-Downing, CC Lee, S Singh, T Li, ME Dudley, NP Restifo, SA Rosenberg, US Kammula |
Science Translational Medicine | 2012 |
Novel Serial Positive Enrichment Technology Enables Clinical Multiparameter Cell Sorting
C Stemberger, S Dreher, C Tschulik, C Piossek, J Bet, TN Yamamoto, M Schiemann, M Neuenhahn, K Martin, M Schlapschy, A Skerra, T Schmidt, M Edinger, SR Riddell, L Germeroth, DH Busch |
PloS one | 2012 |
Gene Therapy-Mediated Reprogramming Tumor Infiltrating T Cells Using IL-2 and Inhibiting NF-κB Signaling Improves the Efficacy of Immunotherapy in a Brain Cancer Model
Y Mineharu, AK Muhammad, K Yagiz, M Candolfi, KM Kroeger, W Xiong, M Puntel, C Liu, E Levy, C Lugo, A Kocharian, JP Allison, MA Curran, PR Lowenstein, MG Castro |
Neurotherapeutics | 2012 |
Lessons in Nonhuman Primate Models for AIDS Vaccine Research: From Minefields to Milestones
JD Lifson, NL Haigwood |
Cold Spring Harbor Perspectives in Medicine | 2012 |
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer
E Provasi, P Genovese, A Lombardo, Z Magnani, PQ Liu, A Reik, V Chu, DE Paschon, L Zhang, J Kuball, B Camisa, A Bondanza, G Casorati, M Ponzoni, F Ciceri, C Bordignon, PD Greenberg, MC Holmes, PD Gregory, L Naldini, C Bonini |
Nature Medicine | 2012 |
Paths to stemness: building the ultimate antitumour T cell
L Gattinoni, CA Klebanoff, NP Restifo |
Nature Reviews Cancer | 2012 |
The Past, Present, and Future of Adoptive T Cell Therapy
D Choi, TG Kim, YC Sung |
Immune Network | 2012 |
Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation
M Bleakley, CJ Turtle, SR Riddell |
Expert Review of Hematology | 2012 |
Improving TCR Gene Therapy for Treatment of Haematological Malignancies
E Nicholson, S Ghorashian, H Stauss |
Advances in Hematology | 2012 |
Stimulation of Wnt/ß-Catenin Pathway in Human CD8+ T Lymphocytes from Blood and Lung Tumors Leads to a Shared Young/Memory Phenotype
MA Forget, Y Huon, A Reuben, C Grange, M Liberman, J Martin, AM Mes-Masson, N Arbour, R Lapointe |
PloS one | 2012 |
How (specific) would you like your T-cells today? Generating T-cell therapeutic function through TCR-gene transfer
I Daniel-Meshulam, S Ya'akobi, C Ankri, CJ Cohen |
Frontiers in immunology | 2012 |
Current translational and clinical practices in hematopoietic cell and gene therapy
DL Digiusto, HP Kiem |
Cytotherapy | 2012 |
Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails
S Yang, Y Ji, L Gattinoni, L Zhang, Z Yu, NP Restifo, SA Rosenberg, RA Morgan |
Cancer Immunology, Immunotherapy | 2012 |
A combination of local inflammation and central memory T cells potentiates immunotherapy in the skin
S Fiorenza, TJ Kenna, I Comerford, S McColl, RJ Steptoe, GR Leggatt, IH Frazer |
Journal of immunology (Baltimore, Md. : 1950) | 2012 |
Phenotypic and functional attributes of lentivirus-modified CD19-specific human CD8+ central memory T cells manufactured at clinical scale
X Wang, A Naranjo, CE Brown, C Bautista, CW Wong, WC Chang, B Aguilar, JR Ostberg, SR Riddell, SJ Forman, MC Jensen |
Journal of immunotherapy (Hagerstown, Md. : 1997) | 2012 |
Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?
CA Klebanoff, L Gattinoni, NP Restifo |
Journal of immunotherapy (Hagerstown, Md. : 1997) | 2012 |
Ex vivo interleukin-12-priming during CD8(+) T cell activation dramatically improves adoptive T cell transfer antitumor efficacy in a lymphodepleted host
MP Rubinstein, CA Cloud, TE Garrett, CJ Moore, KM Schwartz, CB Johnson, DH Craig, ML Salem, CM Paulos, DJ Cole |
Journal of the American College of Surgeons | 2012 |
The Future Is Now: Chimeric Antigen Receptors as New Targeted Therapies for Childhood Cancer
DW Lee, DM Barrett, C Mackall, R Orentas, SA Grupp |
Clinical cancer research | 2012 |
Adoptive immunotherapy for cancer: harnessing the T cell response
NP Restifo, ME Dudley, SA Rosenberg |
Nature Reviews Immunology | 2012 |
Investigative and clinical applications of synthetic immune synapses
MC Milone, LC Kam |
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology | 2012 |
Chimeric antigen receptor--modified T cells: clinical translation in stem cell transplantation and beyond
SR Riddell, MC Jensen, CH June |
Biology of Blood and Marrow Transplantation | 2012 |
Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotype
AG Chapuis, JA Thompson, KA Margolin, R Rodmyre, IP Lai, K Dowdy, EA Farrar, S Bhatia, DE Sabath, J Cao, Y Li, C Yee |
Proceedings of the National Academy of Sciences | 2012 |
Generation and administration of HA-1-specific T-cell lines for the treatment of patients with relapsed leukemia after allogeneic stem cell transplantation: a pilot study
P Meij, I Jedema, MA van der Hoorn, R Bongaerts, L Cox, AR Wafelman, EW Marijt, R Willemze, JH Falkenburg |
Haematologica | 2012 |
Harnessing Autophagy for Adoptive T Cell Therapy
S Amarnath, DH Fowler |
Immunotherapy | 2012 |
Immunological milieu in the peritoneal cavity at laparotomy for gastric cancer
A Yoneda, S Ito, S Susumu, M Matsuo, K Taniguchi, Y Tajima, S Eguchi, T Kanematsu, Y Nagata |
World journal of gastroenterology : WJG | 2012 |
New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer
DF Stroncek, C Berger, MA Cheever, RW Childs, ME Dudley, P Flynn, L Gattinoni, JR Heath, M Kalos, FM Marincola, JS Miller, G Mostoslavsky, DJ Powell, M Rao, NP Restifo, SA Rosenberg, J O'Shea, CJ Melief |
Journal of Translational Medicine | 2012 |
Tumor-Infiltrating Lymphocytes in Melanoma
S Lee, K Margolin |
Current Oncology Reports | 2012 |
Engineered T cells for anti-cancer therapy
CJ Turtle, M Hudecek, MC Jensen, SR Riddell |
Current Opinion in Immunology | 2012 |
Graft-versus-leukemia Effect of HLA-haploidentical Central-memory T-cells Expanded With Leukemic APCs and Modified With a Suicide Gene
M Casucci, SK Perna, L Falcone, B Camisa, Z Magnani, M Bernardi, A Crotta, C Tresoldi, K Fleischhauer, M Ponzoni, S Gregori, FC Cappio, F Ciceri, C Bordignon, A Cignetti, A Bondanza, C Bonini |
Molecular Therapy | 2012 |
Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions: CARs for T cell Immunotherapy
KJ Curran, HJ Pegram, RJ Brentjens |
The Journal of Gene Medicine | 2012 |
Stem-like tumor-initiating cells isolated from IL13Rα2 expressing gliomas are targeted and killed by IL13-zetakine-redirected T Cells
CE Brown, R Starr, B Aguilar, AF Shami, C Martinez, M D'Apuzzo, ME Barish, SJ Forman, MC Jensen |
Clinical cancer research | 2012 |
Agonistic antibody to CD40 boosts the antitumor activity of adoptively transferred T cells in vivo
C Liu, CM Lewis, Y Lou, C Xu, W Peng, Y Yang, AH Gelbard, G Lizée, D Zhou, WW Overwijk, P Hwu |
Journal of immunotherapy (Hagerstown, Md. : 1997) | 2012 |
Moving Successful Virus-specific T-cell Therapy for Hematopoietic Stem Cell Recipients to Late Phase Clinical Trials
C Rooney, A Leen |
Molecular Therapy — Nucleic Acids | 2012 |
Loss of antigen cross-presentation after complete tumor resection is associated with the generation of protective tumor-specific CD8(+) T-cell immunity
MD Brown, R der Most, JB Vivian, RA Lake, I Larma, BW Robinson, AJ Currie |
OncoImmunology | 2012 |
Lenalidomide-induced immunomodulation in multiple myeloma: impact on vaccines and antitumor responses
K Noonan, L Rudraraju, A Ferguson, A Emerling, MF Pasetti, CA Huff, I Borrello |
Clinical cancer research | 2012 |
Immunology in the clinic review series; focus on cancer: double trouble for tumours: bi-functional and redirected T cells as effective cancer immunotherapies
LA Marr, DE Gilham, JD Campbell, AR Fraser |
Clinical & Experimental Immunology | 2012 |
CARs: Driving T-cell specificity to enhance anti-tumor immunity
Kebriaei P, Kelly SS, Manuri P, Jena B, Jackson R, Shpall E, Champlin R, Cooper LJ |
Frontiers in bioscience (Scholar edition) | 2012 |
Neuroantigen-Specific CD8+ Regulatory T-Cell Function is Deficient During Acute Exacerbation of Multiple Sclerosis
EJ Baughman, JP Mendoza, SB Ortega, CL Ayers, BM Greenberg, EM Frohman, NJ Karandikar |
Journal of Autoimmunity | 2011 |
Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma
CU Louis, B Savoldo, G Dotti, M Pule, E Yvon, GD Myers, C Rossig, HV Russell, O Diouf, E Liu, H Liu, MF Wu, AP Gee, Z Mei, CM Rooney, HE Heslop, MK Brenner |
Blood | 2011 |
HIV-specific CD8+ T cells from HIV+ individuals receiving HAART can be expanded ex vivo to augment systemic and mucosal immunity in vivo
AG Chapuis, C Casper, S Kuntz, J Zhu, A Tjernlund, K Diem, CJ Turtle, ML Cigal, R Velez, S Riddell, L Corey, PD Greenberg |
Blood | 2011 |
Buffered memory: a hypothesis for the maintenance of functional, virus-specific CD8+ T cells during cytomegalovirus infection
CM Snyder |
Immunologic Research | 2011 |
Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy
CS Hinrichs, ZA Borman, L Gattinoni, Z Yu, WR Burns, J Huang, CA Klebanoff, LA Johnson, SP Kerkar, S Yang, P Muranski, DC Palmer, CD Scott, RA Morgan, PF Robbins, SA Rosenberg, NP Restifo |
Blood | 2011 |
Ex vivo gene transfer and correction for cell-based therapies
L Naldini |
Nature Reviews Genetics | 2011 |
Engineered T cells for the adoptive therapy of B-cell chronic lymphocytic leukaemia
P Koehler, P Schmidt, AA Hombach, M Hallek, H Abken |
Advances in Hematology | 2011 |
Chimeric Antigen Receptor (CAR)-Engineered Lymphocytes for Cancer Therapy
CA Ramos, G Dotti |
Expert Opinion on Biological Therapy | 2011 |
In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells
S Yang, L Gattinoni, G Luca, F Liu, Y Ji, Z Yu, NP Restifo, SA Rosenberg, RA Morgan |
Cancer Immunology, Immunotherapy | 2011 |
The Shedding of CD62L (L-Selectin) Regulates the Acquisition of Lytic Activity in Human Tumor Reactive T Lymphocytes
S Yang, F Liu, QJ Wang, SA Rosenberg, RA Morgan |
PloS one | 2011 |
Th17 Cells Are Long Lived and Retain a Stem Cell-like Molecular Signature
P Muranski, ZA Borman, SP Kerkar, CA Klebanoff, Y Ji, L Sanchez-Perez, M Sukumar, RN Reger, Z Yu, SJ Kern, R Roychoudhuri, GA Ferreyra, W Shen, SK Durum, L Feigenbaum, DC Palmer, PA Antony, CC Chan, A Laurence, RL Danner, L Gattinoni, NP Restifo |
Immunity | 2011 |
Priming CD8+ T cells with dendritic cells matured using TLR4 and TLR7/8 ligands together enhances generation of CD8+ T cells retaining CD28
JS Pufnock, M Cigal, LS Rolczynski, E Andersen-Nissen, M Wolfl, MJ McElrath, PD Greenberg |
Blood | 2011 |
Activation of Wnt signaling arrests effector differentiation in human peripheral and cord blood-derived T lymphocytes
S Muralidharan, PJ Hanley, E Liu, R Chakraborty, C Bollard, E Shpall, C Rooney, B Savoldo, J Rodgers, G Dotti |
Journal of immunology (Baltimore, Md. : 1950) | 2011 |
Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia
M Bleakley, SR Riddell |
Immunology and Cell Biology | 2011 |
Immune Reconstitution in Recipients of Photodepleted HLA-Identical Sibling Donor Stem Cell Transplantations: T Cell Subset Frequencies Predict Outcome
ZA McIver, JJ Melenhorst, A Grim, N Naguib, G Weber, V Fellowes, H Khuu, DS Stroncek, SF Leitman, M Battiwalla, AJ Barrett |
Biology of Blood and Marrow Transplantation | 2011 |
CARs on Track in the Clinic
DB Kohn, G Dotti, R Brentjens, B Savoldo, M Jensen, LJ Cooper, CH June, S Rosenberg, M Sadelain, HE Heslop |
Molecular Therapy | 2011 |
Establishment of Antitumor Memory in Humans Using in Vitro-Educated CD8+ T Cells
MO Butler, P Friedlander, MI Milstein, MM Mooney, G Metzler, AP Murray, M Tanaka, A Berezovskaya, O Imataki, L Drury, L Brennan, M Flavin, D Neuberg, K Stevenson, D Lawrence, FS Hodi, EF Velazquez, MT Jaklitsch, SE Russell, M Mihm, LM Nadler, N Hirano |
Science Translational Medicine | 2011 |
Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T cells
U Thiel, S Pirson, C Müller-Spahn, H Conrad, DH Busch, H Bernhard, S Burdach, GH Richter |
British Journal of Cancer | 2011 |
Retinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells
TN Golovina, T Mikheeva, TM Brusko, BR Blazar, JA Bluestone, JL Riley |
PloS one | 2011 |
Biomarkers in T cell therapy clinical trials
M Kalos |
Journal of Translational Medicine | 2011 |
Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells
S Terakura, TN Yamamoto, RA Gardner, CJ Turtle, MC Jensen, SR Riddell |
Blood | 2011 |
Genetically retargeting CD8+ lymphocyte subsets for cancer immunotherapy
CJ Turtle, SR Riddell |
Current Opinion in Immunology | 2011 |
Genetic Modification of T Cells
C Bonini, MK Brenner, HE Heslop, RA Morgan |
Biology of Blood and Marrow Transplantation | 2011 |
Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice
X Wang, C Berger, CL Wong, SJ Forman, SR Riddell, MC Jensen |
Blood | 2011 |
Rapid detection, enrichment and propagation of specific T cell subsets based on cytokine secretion
JD Campbell, A Foerster, V Lasmanowicz, M Niemöller, A Scheffold, M Fahrendorff, G Rauser, M Assenmacher, A Richter |
Clinical & Experimental Immunology | 2011 |
PD-L1 blockade effectively restores strong graft-versus-leukemia effects without graft-versus-host disease after delayed adoptive transfer of T-cell receptor gene-engineered allogeneic CD8+ T cells
W Koestner, M Hapke, J Herbst, C Klein, K Welte, J Fruehauf, A Flatley, DA Vignali, M Hardtke-Wolenski, E Jaeckel, BR Blazar, MG Sauer |
Blood | 2011 |
Activated NKT Cells and NK Cells Render T Cells Resistant to Myeloid-Derived Suppressor Cells and Result in an Effective Adoptive Cellular Therapy against Breast Cancer in the FVBN202 Transgenic Mouse
M Kmieciak, D Basu, KK Payne, A Toor, A Yacoub, XY Wang, L Smith, HD Bear, MH Manjili |
Journal of immunology (Baltimore, Md. : 1950) | 2011 |
Muscle CARs and TcRs: turbo-charged technologies for the (T cell) masses
Kalos M |
Cancer Immunology, Immunotherapy | 2011 |
Graft-versus-leukemia antigen CML66 elicits coordinated B-cell and T-cell immunity after donor lymphocyte infusion
W Zhang, J Choi, W Zeng, SA Rogers, EP Alyea, JG Rheinwald, CM Canning, V Brusic, T Sasada, EL Reinherz, J Ritz, RJ Soiffer, CJ Wu |
Clinical cancer research | 2010 |
IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice
JC Markley, M Sadelain |
Blood | 2010 |
Evaluating the cellular targets of anti-4-1BB agonist antibody during immunotherapy of a pre-established tumor in mice
GH Lin, Y Liu, T Ambagala, BS Kwon, PS Ohashi, TH Watts |
PloS one | 2010 |
Adoptive cell therapy of prostate cancer using female mice-derived T cells that react with prostate antigens
H Yi, X Yu, C Guo, MH Manjili, EA Repasky, XY Wang |
Cancer Immunology, Immunotherapy | 2010 |
NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction
JS Miller, EH Warren, MR van Brink, J Ritz, WD Shlomchik, WJ Murphy, AJ Barrett, HJ Kolb, S Giralt, MR Bishop, BR Blazar, JH Falkenburg |
Biology of Blood and Marrow Transplantation | 2010 |
NCI First International Workshop on the Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: Report from the Committee on Prevention of Relapse Following Allogeneic Cell Transplantation for Hematological Malignancies
EP Alyea, DJ DeAngelo, J Moldrem, JM Pagel, D Przepiorka, M Sadelin, JW Young, S Giralt, M Bishop, S Riddell |
Biology of Blood and Marrow Transplantation | 2010 |
Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer
M Cartellieri, M Bachmann, A Feldmann, C Bippes, S Stamova, R Wehner, A Temme, M Schmitz |
Journal of Biomedicine and Biotechnology | 2010 |
Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation
RJ O’Reilly, T Dao, G Koehne, D Scheinberg, E Doubrovina |
Seminars in Immunology | 2010 |
The B-cell tumor–associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor
M Hudecek, TM Schmitt, S Baskar, MT Lupo-Stanghellini, T Nishida, TN Yamamoto, M Bleakley, CJ Turtle, WC Chang, HA Greisman, B Wood, DG Maloney, MC Jensen, C Rader, SR Riddell |
Blood | 2010 |
The impact of ex vivo clinical grade activation protocols on human T cell phenotype and function for the generation of genetically modified cells for adoptive cell transfer therapy
PC Tumeh, RC Koya, T Chodon, NA Graham, TG Graeber, B Comin-Anduix, A Ribas |
Journal of immunotherapy (Hagerstown, Md. : 1997) | 2010 |
Prevention of Interleukin-2 Withdrawal-Induced Apoptosis in Lymphocytes Retrovirally Cotransduced With Genes Encoding an Antitumor T-cell Receptor and an Antiapoptotic Protein:
A Kalbasi, RK Shrimali, D Chinnasamy, SA Rosenberg |
Journal of immunotherapy (Hagerstown, Md. : 1997) | 2010 |
A Simplified Method for the Clinical-scale Generation of Central Memory-like CD8+ T Cells After Transduction With Lentiviral Vectors Encoding Antitumor Antigen T-cell Receptors
S Yang, ME Dudley, SA Rosenberg, RA Morgan |
Journal of immunotherapy (Hagerstown, Md. : 1997) | 2010 |
Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor
B Jena, G Dotti, LJ Cooper |
Blood | 2010 |
Artificial Antigen-Presenting Cells for Use in Adoptive Immunotherapy
CJ Turtle, SR Riddell |
The Cancer Journal | 2010 |
Application of Adoptive T-Cell Therapy Using Tumor Antigen-Specific T-Cell Receptor Gene Transfer for the Treatment of Human Leukemia
T Ochi, H Fujiwara, M Yasukawa |
Journal of Biomedicine and Biotechnology | 2010 |
Targeting Stat3 in the myeloid compartment drastically improves the in vivo antitumor functions of adoptively transferred T cells
A Herrmann, M Kortylewski, M Kujawski, C Zhang, K Reckamp, B Armstrong, L Wang, C Kowolik, J Deng, R Figlin, H Yu |
Cancer research | 2010 |
Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems
YY Chen, MC Jensen, CD Smolke |
Proceedings of the National Academy of Sciences | 2010 |
A Transposon and Transposase System for Human Application
PB Hackett, DA Largaespada, LJ Cooper |
Molecular Therapy | 2010 |
Rebalancing Immune Specificity and Function in Cancer by T-Cell Receptor Gene Therapy
A Udyavar, TL Geiger |
Archivum Immunologiae et Therapiae Experimentalis | 2010 |
Accelerated Production of Antigen-specific T Cells for Preclinical and Clinical Applications Using Gas-permeable Rapid Expansion Cultureware (G-Rex)
JF Vera, LJ Brenner, U Gerdemann, MC Ngo, U Sili, H Liu, J Wilson, G Dotti, HE Heslop, AM Leen, CM Rooney |
Journal of Immunotherapy | 2010 |
JAK3/STAT5/6 Pathway Alterations Are Associated with Immune Deviation in CD8+ T Cells in Renal Cell Carcinoma Patients
E Cavalcanti, M Gigante, V Mancini, M Battaglia, P Ditonno, C Capobianco, RI Cincione, FP Selvaggi, W Herr, WJ Storkus, L Gesualdo, E Ranieri |
Journal of Biomedicine and Biotechnology | 2010 |
Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens
EH Warren, N Fujii, Y Akatsuka, CN Chaney, JK Mito, KR Loeb, TA Gooley, ML Brown, KK Koo, KV Rosinski, S Ogawa, A Matsubara, FR Appelbaum, SR Riddell |
Blood | 2010 |
Translating Sleeping Beauty transposition into cellular therapies: Victories and challenges
Z Izsvák, PB Hackett, LJ Cooper, Z Ivics |
BioEssays | 2010 |
piggyBacTransposon/Transposase System to Generate CD19-Specific T Cells for the Treatment of B-Lineage Malignancies
PV Manuri, MH Wilson, SN Maiti, T Mi, H Singh, S Olivares, MJ Dawson, H Huls, DA Lee, PH Rao, JM Kaminski, Y Nakazawa, S Gottschalk, P Kebriaei, EJ Shpall, RE Champlin, LJ Cooper |
Human Gene Therapy | 2010 |
Redirecting the Immune Response: Role of Adoptive T Cell Therapy
A Mondino, V Dardalhon, RH Michelini, S Loisel-Meyer, N Taylor |
Human Gene Therapy | 2010 |
PD-1 expression on peripheral CD8+ TEM/TEMRA subsets closely correlated with HCV viral load in chronic hepatitis C patients
T Shen, J Zheng, C Xu, J Liu, W Zhang, F Lu, H Zhuang |
Virology Journal | 2010 |
Exhaustive expansion: A novel technique for analyzing complex data generated by higher-order polychromatic flow cytometry experiments
JC Siebert, L Wang, DP Haley, A Romer, B Zheng, W Munsil, KW Gregory, EB Walker |
Journal of Translational Medicine | 2010 |
Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection
ML Zandvliet, JH Falkenburg, E Liempt, LA Veltrop-Duits, AC Lankester, JS Kalpoe, MG Kester, DM van der Steen, MJ van Tol, R Willemze, HJ Guchelaar, MW Schilham, P Meij |
Haematologica | 2010 |
Combining CD19 redirection and alloanergization to generate tumor-specific human T cells for allogeneic cell therapy of B-cell malignancies
JK Davies, H Singh, H Huls, D Yuk, DA Lee, P Kebriaei, RE Champlin, LM Nadler, EC Guinan, LJ Cooper |
Cancer research | 2010 |
Adoptive T cell therapy of cancer
MK Brenner, HE Heslop |
Current Opinion in Immunology | 2010 |
Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation
AM Leen, T Tripic, CM Rooney |
Expert Opinion on Biological Therapy | 2010 |
A nonhuman primate model for analysis of safety, persistence and function of adoptively transferred T cells
C Berger, M Berger, D Anderson, SR Riddell |
Journal of Medical Primatology | 2010 |
Anti-Transgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CD19-Specific Chimeric Antigen Receptor Re-directed T Cells in Humans
MC Jensen, L Popplewell, LJ Cooper, D DiGiusto, M Kalos, JR Ostberg, SJ Forman |
Biology of Blood and Marrow Transplantation | 2010 |
Tumor-Primed, In Vitro-Activated CD4 + Effector T Cells Establish Long-Term Memory without Exogenous Cytokine Support or Ongoing Antigen Exposure
LX Wang, GE Plautz |
Journal of immunology (Baltimore, Md. : 1950) | 2010 |
Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop.
Williams ME, Connors JM, Dreyling MH, Gascoyne RD, Kahl BS, Leonard JP, Press OW, Wilson WH |
Leukemia & Lymphoma | 2010 |
IL-21-treated naive CD45RA+ CD8+ T cells represent a reliable source for producing leukemia-reactive cytotoxic T lymphocytes with high proliferative potential and early differentiation phenotype
Albrecht J, Frey M, Teschner D, Carbol A, Theobald M, Herr W, Distler E |
Cancer Immunology, Immunotherapy | 2010 |
Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response
GA Rizzuto, T Merghoub, D Hirschhorn-Cymerman, C Liu, AM Lesokhin, D Sahawneh, H Zhong, KS Panageas, MA Perales, G Altan-Bonnet, JD Wolchok, AN Houghton |
Journal of Experimental Medicine | 2009 |
A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy
AN Hasan, WJ Kollen, D Trivedi, A Selvakumar, B Dupont, M Sadelain, RJ O'Reilly |
Journal of immunology (Baltimore, Md. : 1950) | 2009 |
Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts
Y Cui, H Zhang, J Meadors, R Poon, M Guimond, CL Mackall |
Blood | 2009 |
The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor
P Scheinberg, JJ Melenhorst, JM Brenchley, BJ Hill, NF Hensel, PK Chattopadhyay, M Roederer, LJ Picker, DA Price, AJ Barrett, DC Douek |
Blood | 2009 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Treatment of lymphoma with adoptively transferred T cells
BG Till, OW Press |
Expert Opinion on Biological Therapy | 2009 |
Immunobiology of human cytomegalovirus: from bench to bedside
T Crough, R Khanna |
Clinical microbiology reviews | 2009 |
Central Memory CD8 + T Cells Induce Graft-versus-Host Disease and Mediate Graft-versus-Leukemia
H Zheng, C Matte-Martone, D Jain, J McNiff, WD Shlomchik |
Journal of immunology (Baltimore, Md. : 1950) | 2009 |
Fifteen Years of Gene Therapy Based on Chimeric Antigen Receptors: “Are We Nearly There Yet?”
G Dotti, B Savoldo, M Brenner |
Human Gene Therapy | 2009 |
Adoptive T-cell therapy for B-cell malignancies
M Hudecek, LD Anderson, T Nishida, SR Riddell |
Expert Review of Hematology | 2009 |
Safety and immunologic effects of IL-15 administration in nonhuman primates
C Berger, M Berger, RC Hackman, M Gough, C Elliott, MC Jensen, SR Riddell |
Blood | 2009 |
T Cell Receptor Gene Therapy for Cancer
TM Schmitt, GB Ragnarsson, PD Greenberg |
Human Gene Therapy | 2009 |
Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity
CS Hinrichs, ZA Borman, L Cassard, L Gattinoni, R Spolski, Z Yu, L Sanchez-Perez, P Muranski, SJ Kern, C Logun, DC Palmer, Y Ji, RN Reger, WJ Leonard, RL Danner, SA Rosenberg, NP Restifo |
Proceedings of the National Academy of Sciences | 2009 |
Depletion of CD4 T cells enhances immunotherapy for neuroblastoma after syngeneic HSCT but compromises development of antitumor immune memory
W Jing, JA Gershan, BD Johnson |
Blood | 2009 |
Distribution, Persistence, and Efficacy of Adoptively Transferred Central and Effector Memory-Derived Autologous Simian Immunodeficiency Virus-Specific CD8 + T Cell Clones in Rhesus Macaques during Acute Infection
JT Minang, MT Trivett, DL Bolton, CM Trubey, JD Estes, Y Li, J Smedley, R Pung, M Rosati, R Jalah, GN Pavlakis, BK Felber, M Piatak, M Roederer, JD Lifson, DE Ott, C Ohlen |
Journal of immunology (Baltimore, Md. : 1950) | 2009 |
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
HE Heslop, KS Slobod, MA Pule, GA Hale, A Rousseau, CA Smith, CM Bollard, H Liu, MF Wu, RJ Rochester, PJ Amrolia, JL Hurwitz, MK Brenner, CM Rooney |
Blood | 2009 |
Adoptive transfer of virus-specific and tumor-specific T cell immunity
C Berger, CJ Turtle, MC Jensen, SR Riddell |
Current Opinion in Immunology | 2009 |
Highlights of the First International “Immunotherapy in Pediatric Oncology: Progress and Challenges” Meeting
CM Capitini, LJ Cooper, RM Egeler, R Handgretinger, F Locatelli, PM Sondel, CL Mackall |
Journal of Pediatric Hematology/Oncology | 2009 |
Functionally Distinct LAG-3 and PD-1 Subsets on Activated and Chronically Stimulated CD8 T Cells
JF Grosso, MV Goldberg, D Getnet, TC Bruno, HR Yen, KJ Pyle, E Hipkiss, DA Vignali, DM Pardoll, CG Drake |
Journal of immunology (Baltimore, Md. : 1950) | 2009 |
Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation
AM Leen, A Christin, GD Myers, H Liu, CR Cruz, PJ Hanley, AA Kennedy-Nasser, KS Leung, AP Gee, RA Krance, MK Brenner, HE Heslop, CM Rooney, CM Bollard |
Blood | 2009 |
Lymphoma immunotherapy: vaccines, adoptive cell transfer and immunotransplant
J Brody, R Levy |
Immunotherapy | 2009 |
Manufacturing Validation of Biologically Functional T Cells Targeted to CD19 Antigen for Autologous Adoptive Cell Therapy
D Hollyman, J Stefanski, M Przybylowski, S Bartido, O Borquez-Ojeda, C Taylor, R Yeh, V Capacio, M Olszewska, J Hosey, M Sadelain, RJ Brentjens, I Rivière |
Journal of Immunotherapy | 2009 |
Nucleofection of DCs to Generate Multivirus-specific T Cells for Prevention or Treatment of Viral Infections in the Immunocompromised Host
U Gerdemann, AS Christin, JF Vera, CA Ramos, Y Fujita, H Liu, D Dilloo, HE Heslop, MK Brenner, CM Rooney, AM Leen |
Molecular Therapy | 2009 |
Adoptive T cell therapy of cancer
TN Schumacher, NP Restifo |
Current Opinion in Immunology | 2009 |
Engineering lymphocyte subsets: tools, trials and tribulations
CH June, BR Blazar, JL Riley |
Nature reviews. Immunology | 2009 |
The promise and potential pitfalls of chimeric antigen receptors
M Sadelain, R Brentjens, I Rivière |
Current Opinion in Immunology | 2009 |
Trafficking, Persistence, and Activation State of Adoptively Transferred Allogeneic and Autologous Simian Immunodeficiency Virus-Specific CD8 + T Cell Clones during Acute and Chronic Infection of Rhesus Macaques
DL Bolton, JT Minang, MT Trivett, K Song, JJ Tuscher, Y Li, M Piatak, D OConnor, JD Lifson, M Roederer, C Ohlen |
Journal of immunology (Baltimore, Md. : 1950) | 2009 |
Immunotherapy of Human Cancers Using Gene Modified T Lymphocytes
Vera JF, Brenner MK, Dotti G |
Current gene therapy | 2009 |
Advances in cellular therapy: 5th International Symposium on the clinical use of cellular products, 19 and 20 March 2009, Nürnberg, Germany
Ullrich E, Bosch J, Aigner M, Völkl S, Dudziak D, Spriewald B, Schuler G, Andreesen R, Mackensen A |
Cancer Immunology, Immunotherapy | 2009 |
TCR transgenes and transgene cassettes for TCR gene therapy: status in 2008
Uckert W, Schumacher TN |
Cancer Immunology, Immunotherapy | 2009 |
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells
BG Till, MC Jensen, J Wang, EY Chen, BL Wood, HA Greisman, X Qian, SE James, A Raubitschek, SJ Forman, AK Gopal, JM Pagel, CG Lindgren, PD Greenberg, SR Riddell, OW Press |
Blood | 2008 |
Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system
H Singh, PR Manuri, S Olivares, N Dara, MJ Dawson, H Huls, PB Hackett, DB Kohn, EJ Shpall, RE Champlin, LJ Cooper |
Cancer research | 2008 |
Post-transplant adoptive T-cell immunotherapy
NA Aqui, CH June |
Best practice & research. Clinical haematology | 2008 |
Characterizing and optimizing immune responses to leukaemia antigens after allogeneic stem cell transplantation
K Rezvani, CS Lecturer, AJ Barrett |
Best practice & research. Clinical haematology | 2008 |
Adoptive immunotherapy: good habits instilled at youth have long-term benefits
CM Paulos, MM Suhoski, G Plesa, T Jiang, S Basu, TN Golovina, S Jiang, NA Aqui, DJ Powell, BL Levine, RG Carroll, JL Riley, CH June |
Immunologic Research | 2008 |
Cancer treatment: the combination of vaccination with other therapies
MH Andersen, RB Sørensen, D Schrama, IM Svane, JC Becker, PT Straten |
Cancer Immunology, Immunotherapy | 2008 |
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
MA Pule, B Savoldo, GD Myers, C Rossig, HV Russell, G Dotti, MH Huls, E Liu, AP Gee, Z Mei, E Yvon, HL Weiss, H Liu, CM Rooney, HE Heslop, MK Brenner |
Nature Medicine | 2008 |
A heterologous DNA prime/protein boost immunization strategy for rhesus cytomegalovirus
K Abel, L Strelow, Y Yue, MK Eberhardt, KA Schmidt, PA Barry |
Vaccine | 2008 |
Immunotherapy targeting EBV-expressing lymphoproliferative diseases
CM Bollard, LJ Cooper, HE Heslop |
Best practice & research. Clinical haematology | 2008 |
Allogeneic lymphocytes persist and traffic in feral MHC-matched mauritian cynomolgus macaques
JM Greene, BJ Burwitz, AJ Blasky, TL Mattila, JJ Hong, EG Rakasz, RW Wiseman, KJ Hasenkrug, PJ Skinner, SL O'Connor, DH O'Connor |
PloS one | 2008 |